| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin filament binding | MYH1 MYH2 MYH4 MYH6 MYH8 NRAP NEBL MYO5B MYO9B MYO10 SPTAN1 SPTBN1 TRIOBP MYO1B ACTN2 NEB ADD3 CYFIP1 XIRP2 CAPZA3 PLS3 | 2.48e-15 | 227 | 184 | 21 | GO:0051015 |
| GeneOntologyMolecularFunction | microfilament motor activity | 5.10e-11 | 38 | 184 | 9 | GO:0000146 | |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH2 MYH4 MYH6 MYH8 NRAP NEBL MYO5B MYO9B MYO10 SPTAN1 SPTBN1 TRIOBP MYO1B ACTN2 NEB ADD3 LDB3 CYFIP1 XIRP2 CAPZA3 PLS3 | 6.32e-10 | 479 | 184 | 22 | GO:0003779 |
| GeneOntologyMolecularFunction | calmodulin binding | PCYT1A MYH1 MYH2 MYH4 MYH6 MYH8 MYO5B MYO9B MYO10 SPTAN1 SPTBN1 ESRRG MYO1B ADD3 CDK5RAP2 | 3.77e-09 | 230 | 184 | 15 | GO:0005516 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP5PB MYH1 MYH2 MYH4 MYH6 MYH8 ABCA2 MYO5B CENPE ABCA13 MYO9B MYO10 MCM4 MYO1B CHD8 SMC2 SLFN13 NAV3 SMARCA4 DDX60L ASCC3 HSPA4 TOP2B | 1.22e-08 | 614 | 184 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.42e-07 | 118 | 184 | 10 | GO:0003774 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH1 MYH2 MYH4 MYH6 MYH8 NRAP NEBL CLASP1 MYO5B GAPDH CENPE MYO9B MYO10 SPTAN1 SPTBN1 TRIOBP MYO1B ACTN2 NEB ADD3 LDB3 CYFIP1 PTPRC XIRP2 CLTC NAV3 CDK5RAP2 CAPZA3 PLS3 | 2.94e-07 | 1099 | 184 | 29 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP5PB MYH4 MYH8 ABCA2 MYO5B ABCA13 MYO9B MCM4 CHD8 SMC2 SLFN13 NAV3 SMARCA4 DDX60L ASCC3 | 1.52e-05 | 441 | 184 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | natriuretic peptide receptor activity | 2.52e-04 | 3 | 184 | 2 | GO:0016941 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 6.50e-04 | 43 | 184 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP5PB MYH4 MYH8 ABCA2 MYO5B ABCA13 MYO9B MCM4 CHD8 SMC2 ARHGAP5 SLFN13 NAV3 SMARCA4 DDX60L ASCC3 GNAZ | 8.51e-04 | 775 | 184 | 17 | GO:0017111 |
| GeneOntologyBiologicalProcess | actin filament-based process | DOCK2 MYH2 MYH4 MYH6 MYH8 NRAP NEBL CLASP1 MYO5B MYO9B SPTAN1 SPTBN1 TRIOBP MYO1B TSC1 ACTN2 ARFIP2 NEB CYFIP2 ADD3 LDB3 CYFIP1 XIRP2 SCN9A MKLN1 CAPZA3 UTY PLS3 NCKAP1L | 2.57e-09 | 912 | 184 | 29 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin filament organization | NRAP NEBL CLASP1 MYO5B SPTAN1 SPTBN1 TRIOBP MYO1B TSC1 ACTN2 ARFIP2 NEB CYFIP2 ADD3 CYFIP1 XIRP2 CAPZA3 PLS3 NCKAP1L | 1.60e-07 | 509 | 184 | 19 | GO:0007015 |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 4.17e-07 | 18 | 184 | 5 | GO:0033275 | |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 6.98e-07 | 3 | 184 | 3 | GO:0071691 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | DOCK2 MYH6 NRAP NEBL CLASP1 MYO5B SPTAN1 SPTBN1 TRIOBP MYO1B TSC1 ACTN2 ARFIP2 NEB CYFIP2 ADD3 LDB3 CYFIP1 XIRP2 MKLN1 CAPZA3 PLS3 NCKAP1L | 8.35e-07 | 803 | 184 | 23 | GO:0030036 |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | CLASP1 SPTAN1 SPTBN1 TRIOBP TSC1 ACTN2 ARFIP2 CYFIP2 ADD3 CYFIP1 XIRP2 CAPZA3 NCKAP1L | 3.15e-06 | 300 | 184 | 13 | GO:0110053 |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 4.59e-06 | 105 | 184 | 8 | GO:1901879 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | SPTAN1 SPTBN1 TRIOBP ACTN2 NEB CYFIP2 ADD3 CYFIP1 CAPZA3 NCKAP1L | 5.15e-06 | 180 | 184 | 10 | GO:0030832 |
| GeneOntologyBiologicalProcess | protein depolymerization | 5.95e-06 | 144 | 184 | 9 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 5.95e-06 | 144 | 184 | 9 | GO:0043244 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | CLASP1 SPTAN1 SPTBN1 TRIOBP CYFIP2 ADD3 CYFIP1 NAV3 CDK5RAP2 CAPZA3 NCKAP1L | 7.59e-06 | 231 | 184 | 11 | GO:0032271 |
| GeneOntologyBiologicalProcess | muscle filament sliding | 7.75e-06 | 15 | 184 | 4 | GO:0030049 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | CLASP1 SPTAN1 SPTBN1 TRIOBP TSC1 ACTN2 ARFIP2 NEB CYFIP2 ADD3 CYFIP1 XIRP2 CAPZA3 NCKAP1L | 9.56e-06 | 384 | 184 | 14 | GO:0032956 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | CLASP1 SPTAN1 SPTBN1 TRIOBP TSC1 ACTN2 ARFIP2 CYFIP2 ADD3 CYFIP1 XIRP2 NAV3 CDK5RAP2 CAPZA3 NCKAP1L | 9.62e-06 | 438 | 184 | 15 | GO:1902903 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 9.73e-06 | 153 | 184 | 9 | GO:0030048 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | NPR1 NPR3 MYO5B SPTAN1 SPTBN1 TRIOBP TSC1 ACTN2 PPARD NEB CYFIP2 ADD3 ADM ARHGAP5 CYFIP1 FGA CAPZA3 NCKAP1L | 1.13e-05 | 618 | 184 | 18 | GO:0090066 |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | SET CLASP1 SPTAN1 SPTBN1 TRIOBP ACTN2 ADD3 CLTC NAV3 SMARCA4 CAPZA3 UVRAG | 1.25e-05 | 291 | 184 | 12 | GO:0032984 |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.49e-05 | 89 | 184 | 7 | GO:1901880 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYH6 NRAP NEBL CLASP1 MYO5B SPTAN1 SPTBN1 TRIOBP MYO1B TSC1 ACTN2 ARFIP2 NEB CYFIP2 ADD3 LDB3 CYFIP1 XIRP2 NAV3 CDK5RAP2 CAPZA3 PLS3 NCKAP1L | 1.52e-05 | 957 | 184 | 23 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 1.72e-05 | 61 | 184 | 6 | GO:0030834 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | CLASP1 SPTAN1 SPTBN1 TRIOBP TSC1 ACTN2 ARFIP2 NEB CYFIP2 ADD3 CYFIP1 XIRP2 CLTC NAV3 CDK5RAP2 CAPZA3 NCKAP1L | 1.80e-05 | 579 | 184 | 17 | GO:0051493 |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 2.71e-05 | 66 | 184 | 6 | GO:0030042 | |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | SPTAN1 SPTBN1 TRIOBP ACTN2 CYFIP2 ADD3 CYFIP1 CAPZA3 NCKAP1L | 3.11e-05 | 177 | 184 | 9 | GO:0008064 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 3.19e-05 | 100 | 184 | 7 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | CLASP1 SPTAN1 SPTBN1 TRIOBP TSC1 ACTN2 ARFIP2 NEB CYFIP2 ADD3 CYFIP1 XIRP2 CAPZA3 NCKAP1L | 4.09e-05 | 438 | 184 | 14 | GO:0032970 |
| GeneOntologyBiologicalProcess | protein polymerization | CLASP1 SPTAN1 SPTBN1 TRIOBP CYFIP2 ADD3 CYFIP1 NAV3 FGA CDK5RAP2 CAPZA3 NCKAP1L | 4.84e-05 | 334 | 184 | 12 | GO:0051258 |
| GeneOntologyBiologicalProcess | actin filament capping | 5.45e-05 | 46 | 184 | 5 | GO:0051693 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 8.12e-05 | 156 | 184 | 8 | GO:0032989 | |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | 8.12e-05 | 156 | 184 | 8 | GO:0030833 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 8.12e-05 | 156 | 184 | 8 | GO:0010927 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 9.90e-05 | 52 | 184 | 5 | GO:0030835 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 1.21e-04 | 86 | 184 | 6 | GO:0030239 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | MYO5B SPTAN1 SPTBN1 TRIOBP TSC1 ACTN2 NEB CYFIP2 ADD3 ARHGAP5 CYFIP1 CAPZA3 NCKAP1L | 1.23e-04 | 426 | 184 | 13 | GO:0032535 |
| GeneOntologyBiologicalProcess | cellular component disassembly | SET CLASP1 SPTAN1 SPTBN1 TRIOBP NIPSNAP2 ACTN2 ARFIP2 ADD3 CLTC NAV3 SMARCA4 CAPZA3 ASCC3 CTSK UVRAG | 1.37e-04 | 617 | 184 | 16 | GO:0022411 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.46e-04 | 127 | 184 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 1.46e-04 | 89 | 184 | 6 | GO:0055002 | |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | SPTAN1 SPTBN1 TRIOBP ACTN2 CYFIP2 ADD3 CYFIP1 CAPZA3 NCKAP1L | 1.77e-04 | 222 | 184 | 9 | GO:0008154 |
| GeneOntologyBiologicalProcess | actin filament polymerization | 3.15e-04 | 190 | 184 | 8 | GO:0030041 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 3.62e-04 | 194 | 184 | 8 | GO:0051494 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoskeleton organization | 5.22e-04 | 205 | 184 | 8 | GO:0051495 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 5.57e-04 | 75 | 184 | 5 | GO:0030837 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH2 MYH4 MYH6 MYH8 ACACA NEBL MYO5B MYO9B MYO10 SPTAN1 RGS22 SPTBN1 TOPBP1 TRIOBP MYO1B TSC1 ACTN2 NEB LDB3 XIRP2 CAPZA3 PLS3 | 1.26e-09 | 576 | 182 | 23 | GO:0015629 |
| GeneOntologyCellularComponent | myosin complex | 2.04e-09 | 59 | 182 | 9 | GO:0016459 | |
| GeneOntologyCellularComponent | cell cortex | FNBP1 ZHX3 MYH2 CLASP1 MYO5B MYO9B MYO10 SPTAN1 SPTBN1 TSC1 ACTN2 ARFIP2 ADD3 MKLN1 FGA CAPZA3 | 1.70e-07 | 371 | 182 | 16 | GO:0005938 |
| GeneOntologyCellularComponent | muscle myosin complex | 1.91e-07 | 16 | 182 | 5 | GO:0005859 | |
| GeneOntologyCellularComponent | sarcomere | MYH1 MYH2 MYH4 MYH6 MYH8 NRAP NEBL SPTAN1 SPTBN1 ACTN2 NEB LDB3 XIRP2 | 2.98e-07 | 249 | 182 | 13 | GO:0030017 |
| GeneOntologyCellularComponent | myofibril | MYH1 MYH2 MYH4 MYH6 MYH8 NRAP NEBL SPTAN1 SPTBN1 ACTN2 NEB LDB3 XIRP2 | 8.46e-07 | 273 | 182 | 13 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH1 MYH2 MYH4 MYH6 MYH8 NRAP NEBL SPTAN1 SPTBN1 ACTN2 NEB LDB3 XIRP2 | 1.66e-06 | 290 | 182 | 13 | GO:0043292 |
| GeneOntologyCellularComponent | myosin filament | 2.18e-06 | 25 | 182 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 3.96e-06 | 28 | 182 | 5 | GO:0016460 | |
| GeneOntologyCellularComponent | Z disc | 5.45e-05 | 151 | 182 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 1.06e-04 | 166 | 182 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | SCAR complex | 1.35e-04 | 12 | 182 | 3 | GO:0031209 | |
| GeneOntologyCellularComponent | fibrillar center | 4.42e-04 | 156 | 182 | 7 | GO:0001650 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 5.68e-04 | 19 | 182 | 3 | GO:0098871 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH1 MYH2 MYH4 MYH6 MYH8 NRAP NEBL CLASP1 CENPE MYO9B SPTAN1 SPTBN1 MYO1B TSC1 ACTN2 NEB LDB3 XIRP2 CLTC NAV3 CDK5RAP2 PLS3 | 6.15e-04 | 1179 | 182 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | filopodium tip | 6.64e-04 | 20 | 182 | 3 | GO:0032433 | |
| GeneOntologyCellularComponent | supramolecular polymer | MYH1 MYH2 MYH4 MYH6 MYH8 NRAP NEBL CLASP1 CENPE MYO9B SPTAN1 SPTBN1 MYO1B TSC1 ACTN2 NEB LDB3 XIRP2 CLTC NAV3 CDK5RAP2 PLS3 | 6.73e-04 | 1187 | 182 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 9.42e-04 | 129 | 182 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | tertiary granule lumen | 1.34e-03 | 55 | 182 | 4 | GO:1904724 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 1.46e-03 | 26 | 182 | 3 | GO:0099571 | |
| GeneOntologyCellularComponent | actin filament | 1.78e-03 | 146 | 182 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | fibrinogen complex | 2.04e-03 | 8 | 182 | 2 | GO:0005577 | |
| GeneOntologyCellularComponent | ruffle | 2.23e-03 | 206 | 182 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | vesicle lumen | 2.59e-03 | 332 | 182 | 9 | GO:0031983 | |
| GeneOntologyCellularComponent | spectrin | 2.61e-03 | 9 | 182 | 2 | GO:0008091 | |
| Domain | Myosin_head_motor_dom | 7.90e-11 | 38 | 181 | 9 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 7.90e-11 | 38 | 181 | 9 | PS51456 | |
| Domain | Myosin_head | 7.90e-11 | 38 | 181 | 9 | PF00063 | |
| Domain | MYSc | 7.90e-11 | 38 | 181 | 9 | SM00242 | |
| Domain | IQ | 1.58e-09 | 71 | 181 | 10 | PF00612 | |
| Domain | IQ | 5.90e-09 | 81 | 181 | 10 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.67e-08 | 90 | 181 | 10 | IPR000048 | |
| Domain | IQ | 2.30e-08 | 93 | 181 | 10 | PS50096 | |
| Domain | Myosin_N | 2.25e-07 | 15 | 181 | 5 | PF02736 | |
| Domain | Myosin_N | 2.25e-07 | 15 | 181 | 5 | IPR004009 | |
| Domain | Myosin_tail_1 | 6.26e-07 | 18 | 181 | 5 | PF01576 | |
| Domain | Myosin_tail | 6.26e-07 | 18 | 181 | 5 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 8.42e-07 | 19 | 181 | 5 | IPR027401 | |
| Domain | - | 8.42e-07 | 19 | 181 | 5 | 4.10.270.10 | |
| Domain | Nebulin | 3.56e-06 | 4 | 181 | 3 | PF00880 | |
| Domain | NEBULIN | 3.56e-06 | 4 | 181 | 3 | PS51216 | |
| Domain | NEBU | 3.56e-06 | 4 | 181 | 3 | SM00227 | |
| Domain | Nebulin | 3.56e-06 | 4 | 181 | 3 | IPR013998 | |
| Domain | Nebulin_repeat | 3.56e-06 | 4 | 181 | 3 | IPR000900 | |
| Domain | P-loop_NTPase | MYH1 MYH2 MYH4 MYH6 MYH8 ABCA2 MYO5B CENPE ABCA13 MYO9B MYO10 MCM4 MYO1B CHD8 SMC2 ARHGAP5 SLFN13 NAV3 SMARCA4 DDX60L ASCC3 GNAZ | 2.55e-05 | 848 | 181 | 22 | IPR027417 |
| Domain | Spectrin | 6.54e-05 | 23 | 181 | 4 | PF00435 | |
| Domain | Cytoplasmic_FMR1-int | 9.34e-05 | 2 | 181 | 2 | IPR008081 | |
| Domain | FragX_IP | 9.34e-05 | 2 | 181 | 2 | PF05994 | |
| Domain | Spectrin_repeat | 1.68e-04 | 29 | 181 | 4 | IPR002017 | |
| Domain | ANF_RECEPTORS | 2.78e-04 | 3 | 181 | 2 | PS00458 | |
| Domain | ANPR/GUC | 2.78e-04 | 3 | 181 | 2 | IPR001170 | |
| Domain | DUF1394 | 5.53e-04 | 4 | 181 | 2 | IPR009828 | |
| Domain | DUF1394 | 5.53e-04 | 4 | 181 | 2 | PF07159 | |
| Domain | DUF3338 | 5.53e-04 | 4 | 181 | 2 | PF11819 | |
| Domain | DUF3338 | 5.53e-04 | 4 | 181 | 2 | IPR021774 | |
| Domain | BRK | 1.37e-03 | 6 | 181 | 2 | SM00592 | |
| Domain | BRK_domain | 1.37e-03 | 6 | 181 | 2 | IPR006576 | |
| Domain | EFhand_Ca_insen | 1.37e-03 | 6 | 181 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 1.37e-03 | 6 | 181 | 2 | IPR014837 | |
| Domain | BRK | 1.37e-03 | 6 | 181 | 2 | PF07533 | |
| Domain | ACTININ_2 | 1.37e-03 | 23 | 181 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.37e-03 | 23 | 181 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.37e-03 | 23 | 181 | 3 | IPR001589 | |
| Pubmed | ATP5PB MYH1 MYH2 MYH4 MYH6 MYH8 SET MYO5B SPTAN1 UGGT1 SPTBN1 NIPSNAP2 MYO1B TSC1 APOB ACTN2 PTBP1 SRBD1 PDE10A NEB SMC2 TFAM CYFIP2 CREBRF PHF20L1 SACS DNAJC11 CLTC CEP83 SCN9A TOP2B CCDC158 BBOF1 | 1.88e-12 | 1442 | 187 | 33 | 35575683 | |
| Pubmed | MYH8 SET HIVEP1 NRAP GAPDH SPTBN1 ESRRG NIPSNAP2 ACTN2 DZIP1 NEB PAF1 CCDC141 XIRP2 CLTC FTH1 MKLN1 CDK5RAP2 TAF1 ZMYM4 | 3.75e-12 | 497 | 187 | 20 | 23414517 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATP5PB SET HIVEP1 ACACA GAPDH SPTAN1 RGS22 UGGT1 SPTBN1 MCM4 MYO1B APOB PTBP1 PPAT SMC2 CYFIP2 SLC38A1 TXLNA THADA CYFIP1 DNAJC11 EIF3L CLTC CSTB SMARCA4 UTP20 HSD17B10 ITM2B HSPA4 PLS3 TOP2B | 3.44e-11 | 1425 | 187 | 31 | 30948266 |
| Pubmed | 8.87e-11 | 7 | 187 | 5 | 16819597 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ATP5PB SET SPTAN1 SPTBN1 TOPBP1 NIPSNAP2 MCM4 PTBP1 PPAT PAF1 SMC2 CYFIP2 TXLNA CYFIP1 DNAJC11 EIF3L CLTC CSTB SMARCA4 COMMD10 HSD17B10 HSPA4 PLS3 | 2.27e-10 | 847 | 187 | 23 | 35235311 |
| Pubmed | ATP5PB MYH6 CLASP1 MYO5B GAPDH SPTAN1 SPTBN1 PHYHIP NIPSNAP2 TSC1 ACTN2 PTBP1 TFAM CYFIP2 ADD3 GRAMD1B ARHGAP5 DZANK1 CYFIP1 SACS EIF3L CLTC FTH1 FGA SMARCA4 GNAZ HSPA4 PLS3 | 3.58e-09 | 1431 | 187 | 28 | 37142655 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | HIVEP1 CLASP1 CENPE MYO9B HIPK1 TOPBP1 MECOM MYO1B TSC1 AASDH PAF1 ARFGEF3 CYFIP1 CLTC CSTB HSD17B10 GARRE1 ZMYM4 | 3.68e-09 | 588 | 187 | 18 | 38580884 |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 4.03e-09 | 5 | 187 | 4 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 4.03e-09 | 5 | 187 | 4 | 12919077 | |
| Pubmed | 4.03e-09 | 5 | 187 | 4 | 6196357 | ||
| Pubmed | 8.20e-09 | 14 | 187 | 5 | 33742095 | ||
| Pubmed | 1.20e-08 | 6 | 187 | 4 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.20e-08 | 6 | 187 | 4 | 10077619 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 1.20e-08 | 6 | 187 | 4 | 10588881 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYH4 ACACA MYO9B UGGT1 MYO1B PTBP1 NBAS CLTC UTP20 ASCC3 TOP2B | 1.44e-08 | 202 | 187 | 11 | 33005030 |
| Pubmed | 2.80e-08 | 7 | 187 | 4 | 35210422 | ||
| Pubmed | ATP5PB MYH1 MYH6 MYH8 GAPDH SPTBN1 NIPSNAP2 ACTN2 TFAM LDB3 FGA HSD17B10 PLS3 | 3.38e-08 | 331 | 187 | 13 | 29199018 | |
| Pubmed | 4.16e-08 | 131 | 187 | 9 | 28634551 | ||
| Pubmed | TDRD15 FAT4 ACACA GAPDH CCDC146 APOB PTBP1 ARFIP2 ADCY9 ADD3 SLC38A1 ARFGEF3 PPP2R3A THADA SLFN13 CLTC CDK5RAP2 ZFHX3 HSD17B10 | 4.84e-08 | 777 | 187 | 19 | 35844135 | |
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 5.57e-08 | 8 | 187 | 4 | 14667415 | |
| Pubmed | 5.57e-08 | 8 | 187 | 4 | 3864153 | ||
| Pubmed | ACACA GAPDH SPTAN1 SPTBN1 PTBP1 SMC2 SLC38A1 CYFIP1 EIF3L CLTC CSTB HSD17B10 ASCC3 PLS3 TOP2B | 6.63e-08 | 484 | 187 | 15 | 31995728 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ACACA GAPDH MYO9B SPTAN1 SPTBN1 ADNP2 MCM4 MYO1B TSC1 CHD8 PTBP1 SRBD1 SMC2 DUS3L TFAM RLF CYFIP1 EIF3L CLTC SMARCA4 UTP20 DDX60L ASCC3 HSPA4 TOP2B | 8.07e-08 | 1353 | 187 | 25 | 29467282 |
| Pubmed | 1.04e-07 | 22 | 187 | 5 | 24301466 | ||
| Pubmed | ATP5PB FAM184A SPTAN1 UGGT1 SPTBN1 TRIOBP DZIP1 PAF1 TFAM ADCY9 ADD3 GRAMD1B NBAS TXLNA THADA SACS ERAP2 DNAJC11 CLTC CDK5RAP2 HSD17B10 ASCC3 ITM2B HSPA4 PLS3 TOP2B | 1.27e-07 | 1487 | 187 | 26 | 33957083 | |
| Pubmed | DOCK2 FNBP1 ZHX3 SET HIVEP1 CLASP1 GAPDH MCM4 CHD8 AASDH PTBP1 PPAT PAF1 SMC2 CCDC7 RLF TXLNA CLTC SMARCA4 HSPA4 ZMYM4 TOP2B | 1.42e-07 | 1103 | 187 | 22 | 34189442 | |
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 1.53e-07 | 3 | 187 | 3 | 26059207 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ATP5PB PCYT1A SET ACACA CLASP1 GAPDH SPTAN1 UGGT1 SPTBN1 NIPSNAP2 MCM4 TSC1 PTBP1 PAF1 SMC2 TXLNA CYFIP1 EIF3L CLTC CSTB SMARCA4 HSD17B10 HSPA4 PLS3 TOP2B | 1.88e-07 | 1415 | 187 | 25 | 28515276 |
| Pubmed | MYH1 ZHX3 HIVEP1 NEBL AVL9 TRMT11 PDE10A ARFIP2 PP2D1 CCDC7 SLC38A1 DZANK1 TMTC1 PHF20L1 SCN9A TSPAN6 PLS3 | 2.11e-07 | 686 | 187 | 17 | 29987050 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PCYT1A ZHX3 HIVEP1 ZNF570 TOPBP1 ADNP2 CHD8 SRBD1 SUV39H2 RLF PHF20L1 SMARCA4 TAF1 ZMYM4 TOP2B AFF4 | 2.20e-07 | 608 | 187 | 16 | 36089195 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FNBP1 ZHX3 HIVEP1 ACACA CLASP1 SPTAN1 SPTBN1 MCM4 SH2D4A PTPRC XPO6 TLE4 CLTC FTH1 SMARCA4 UTP20 ZMYM4 TOP2B | 2.32e-07 | 774 | 187 | 18 | 15302935 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZHX3 HIVEP1 GAPDH TOPBP1 MCM4 CHD8 PTBP1 PAF1 TFAM CYFIP2 CYFIP1 EIF3L CLTC SMARCA4 PARN HSD17B10 TAF1 ZMYM4 TOP2B AFF4 | 2.51e-07 | 954 | 187 | 20 | 36373674 |
| Pubmed | 2.59e-07 | 11 | 187 | 4 | 8136524 | ||
| Pubmed | ATP5PB MYH2 SET SPTAN1 UGGT1 SPTBN1 TRIOBP MYO1B PTBP1 SMC2 TFAM GRAMD1B ARFGEF3 NBAS THADA EIF3L CLTC COMMD10 HSD17B10 DDX60L ASCC3 HSPA4 GARRE1 PLS3 TOP2B | 2.60e-07 | 1440 | 187 | 25 | 30833792 | |
| Pubmed | 2.66e-07 | 118 | 187 | 8 | 30979931 | ||
| Pubmed | ACACA GAPDH SPTAN1 CHD8 PAF1 SMC2 ADD3 CYFIP1 TET1 CLTC SMARCA4 TAF1 ASCC3 PLS3 ZMYM4 | 3.33e-07 | 549 | 187 | 15 | 38280479 | |
| Pubmed | 3.41e-07 | 83 | 187 | 7 | 9039502 | ||
| Pubmed | FNBP1 ZHX3 CLASP1 AVL9 MYO10 HIPK1 TSC1 GRAMD1B ARFGEF3 TLE4 PLCL2 CLTC NAV3 | 3.64e-07 | 407 | 187 | 13 | 12693553 | |
| Pubmed | DOCK2 ATP5PB ABCA2 CLASP1 GAPDH CENPE MYO9B CTSC MCM4 PTBP1 CYFIP2 GRAMD1B NBAS TXLNA PTPRC EIF3L CLTC SMARCA4 ASCC3 ITM2B ARHGAP45 NCKAP1L | 3.76e-07 | 1168 | 187 | 22 | 19946888 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | SET CTSC SPTAN1 UGGT1 SPTBN1 XDH MCM4 PTBP1 SMC2 CLTC HSPA4 NCKAP1L | 4.11e-07 | 344 | 187 | 12 | 30333137 |
| Pubmed | ATP5PB ACACA SPTAN1 SPTBN1 MCM4 SMC2 ADD3 CYFIP1 EIF3L CLTC SMARCA4 HSD17B10 ASCC3 HSPA4 PLS3 TOP2B | 4.17e-07 | 638 | 187 | 16 | 33239621 | |
| Pubmed | SPTBN1 ACTN2 PAF1 ADCY9 ADD3 NBAS FTH1 SMARCA4 PHYHIPL HSPA4 | 4.38e-07 | 225 | 187 | 10 | 25277244 | |
| Pubmed | ATP5PB FNBP1 SET GAPDH SPTBN1 MCM4 PTBP1 SMC2 CYFIP2 DZANK1 TXLNA EIF3L CLTC MKLN1 HSD17B10 ASCC3 HSPA4 PLS3 | 4.41e-07 | 809 | 187 | 18 | 32129710 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH2 MYH4 MYH6 MYH8 SPTAN1 UGGT1 SPTBN1 MCM4 MYO1B ACTN2 THADA EIF3L CLTC FTH1 HSPA4 | 5.02e-07 | 647 | 187 | 16 | 26618866 |
| Pubmed | Interaction network of human early embryonic transcription factors. | HIVEP1 GAPDH MECOM CHD8 TFAM RLF TLE4 TET1 SMARCA4 ZFHX3 TAF1 ZMYM4 | 5.08e-07 | 351 | 187 | 12 | 38297188 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH1 MYH2 MYH6 MYH8 CLASP1 TNS2 MYO1B EFCAB14 CYFIP2 GRAMD1B TXLNA CYFIP1 CCDC198 EIF3L CDK5RAP2 PARN DDX60L HSPA4 AFF4 | 5.42e-07 | 910 | 187 | 19 | 36736316 |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 5.57e-07 | 13 | 187 | 4 | 8404542 | |
| Pubmed | 6.09e-07 | 4 | 187 | 3 | 20357587 | ||
| Pubmed | 6.09e-07 | 4 | 187 | 3 | 1985022 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 6.09e-07 | 4 | 187 | 3 | 11029314 | |
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 6.09e-07 | 4 | 187 | 3 | 18417546 | |
| Pubmed | 6.09e-07 | 4 | 187 | 3 | 10388558 | ||
| Pubmed | 6.09e-07 | 4 | 187 | 3 | 11023856 | ||
| Pubmed | 6.09e-07 | 4 | 187 | 3 | 23985323 | ||
| Pubmed | Deficiency of Myo18B in mice results in embryonic lethality with cardiac myofibrillar aberrations. | 6.09e-07 | 4 | 187 | 3 | 18761673 | |
| Pubmed | 7.15e-07 | 58 | 187 | 6 | 21884692 | ||
| Pubmed | 7.77e-07 | 14 | 187 | 4 | 27184118 | ||
| Pubmed | 7.77e-07 | 14 | 187 | 4 | 24938781 | ||
| Pubmed | DOCK2 ATP5PB TDRD15 MYH1 MYH2 MYH4 MYH6 MYH8 SET GAPDH MYO9B MCM4 PTBP1 NEB EIF3L CLTC CSTB HSD17B10 | 8.10e-07 | 844 | 187 | 18 | 25963833 | |
| Pubmed | ZHX3 FAT4 PRMT8 HIVEP1 ACACA MYO5B GAPDH TNS2 ACTN2 PTBP1 DZANK1 PPP2R3A SACS TAF1 HSPA4 | 1.19e-06 | 608 | 187 | 15 | 16713569 | |
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 1.40e-06 | 16 | 187 | 4 | 19922871 | |
| Pubmed | 1.40e-06 | 16 | 187 | 4 | 25987543 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | DOCK2 TRIOBP PTBP1 SMC2 TFAM CYFIP2 TXLNA PTPRC CD22 EIF3L CLTC HSD17B10 ASCC3 ARHGAP45 HSPA4 TOP2B | 1.43e-06 | 701 | 187 | 16 | 30196744 |
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 1.52e-06 | 5 | 187 | 3 | 30737693 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | ATP5PB MYH2 MYH4 SET ACACA CLASP1 GAPDH UGGT1 NIPSNAP2 MYO1B TSC1 SMC2 CREBRF TXLNA SH2D4A XPO6 EIF3L CLTC MKLN1 CSTB SMARCA4 PLS3 | 1.79e-06 | 1284 | 187 | 22 | 17353931 |
| Pubmed | 1.85e-06 | 68 | 187 | 6 | 14676191 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | DOCK2 ATP5PB ABCA2 ACACA GAPDH SPTAN1 UGGT1 SPTBN1 MYO1B CHD8 PTBP1 CYFIP2 NBAS CLTC ZFHX3 HSD17B10 HSPA4 | 1.96e-06 | 807 | 187 | 17 | 30575818 |
| Pubmed | MYO9B MYO10 SPTAN1 SPTBN1 MCM4 CHD8 TXLNA SACS CLTC SMARCA4 FGL1 | 2.08e-06 | 332 | 187 | 11 | 37433992 | |
| Pubmed | ATP5PB GAPDH SPTAN1 SPTBN1 PHYHIP ACTN2 PDE10A CYFIP2 CYFIP1 CLTC PHYHIPL HSPA4 | 2.15e-06 | 403 | 187 | 12 | 30562941 | |
| Pubmed | 3.02e-06 | 6 | 187 | 3 | 20417199 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 3.02e-06 | 6 | 187 | 3 | 17559643 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | SET GAPDH SPTAN1 UGGT1 MCM4 PTBP1 SMC2 DCUN1D4 EIF3L CLTC HSD17B10 HSPA4 PLS3 | 3.19e-06 | 495 | 187 | 13 | 28581483 |
| Pubmed | 3.67e-06 | 20 | 187 | 4 | 18723693 | ||
| Pubmed | ATP5PB ACACA GAPDH SPTAN1 SPTBN1 APBA1 TRIOBP NIPSNAP2 PTBP1 ADD3 GRAMD1B ARFGEF3 FRMD4A DZANK1 DNAJC11 CLTC MKLN1 NAV3 CSTB HSD17B10 | 3.80e-06 | 1139 | 187 | 20 | 36417873 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PCYT1A SET ACACA GAPDH CTSC SPTAN1 UGGT1 SPTBN1 MCM4 PTBP1 ARFIP2 PPAT PAF1 SMC2 DUS3L CYFIP1 SH2D4A EIF3L FTH1 CSTB HSD17B10 HSPA4 PLS3 | 3.93e-06 | 1455 | 187 | 23 | 22863883 |
| Pubmed | SET ACACA NEBL MYO5B GAPDH MYO9B SPTAN1 SPTBN1 MCM4 MYO1B PTBP1 SMC2 CYFIP2 CYFIP1 ERAP2 DNAJC11 CLTC HSD17B10 ASCC3 HSPA4 AFF4 | 4.09e-06 | 1247 | 187 | 21 | 27684187 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PCYT1A SET ACACA GAPDH SPTAN1 UGGT1 SPTBN1 MCM4 MYO1B PTBP1 PAF1 SMC2 CYFIP2 CYFIP1 EIF3L CLTC HSD17B10 ASCC3 HSPA4 PLS3 | 4.32e-06 | 1149 | 187 | 20 | 35446349 |
| Pubmed | MYO5B SPTAN1 UGGT1 SPTBN1 TRIOBP TNS2 MYO1B TSC1 PAF1 ADCY9 CYFIP2 SLC38A1 ARHGAP5 PPP2R3A SH2D4A PTPRC PLCL2 CLTC CDK5RAP2 | 4.33e-06 | 1049 | 187 | 19 | 27880917 | |
| Pubmed | Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes. | 4.51e-06 | 21 | 187 | 4 | 12202484 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | PCYT1A NPR1 SET CLASP1 CENPE TOPBP1 TRIOBP XDH NBAS SH2D4A PHF20L1 EIF3L CLTC FTH1 FGA SMARCA4 CDK5RAP2 PLS3 ZMYM4 TOP2B | 4.67e-06 | 1155 | 187 | 20 | 20360068 |
| Pubmed | CLASP1 CENPE SPTAN1 SPTBN1 TRIOBP TSC1 CHD8 PAF1 SMC2 CYFIP2 DZANK1 TXLNA CYFIP1 CLTC SMARCA4 CDK5RAP2 PARN AFF4 | 5.11e-06 | 963 | 187 | 18 | 28671696 | |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 5.27e-06 | 7 | 187 | 3 | 29758057 | |
| Pubmed | 5.44e-06 | 234 | 187 | 9 | 36243803 | ||
| Pubmed | Mechanical load regulates bone growth via periosteal Osteocrin. | 5.49e-06 | 22 | 187 | 4 | 34260913 | |
| Pubmed | 6.05e-06 | 48 | 187 | 5 | 8884266 | ||
| Pubmed | FAM184A SET NEBL CLASP1 TOPBP1 TRIOBP CHD8 SRBD1 TFAM CYFIP2 CYFIP1 DNAJC11 EIF3L CEP83 UTP20 ZFHX3 PARN HSD17B10 ASCC3 ITM2B PLS3 ZMYM4 AFF4 | 6.26e-06 | 1497 | 187 | 23 | 31527615 | |
| Pubmed | PCYT1A ABCA2 HIPK1 SPTAN1 SPTBN1 APBA1 ADNP2 TRIOBP DZIP1 FRMD4B ADD3 ARHGAP5 SACS CLTC MKLN1 NAV3 SMARCA4 TAF1 TBC1D23 ZMYM4 AFF4 | 6.46e-06 | 1285 | 187 | 21 | 35914814 | |
| Pubmed | MYH2 MYH4 GAPDH SPTAN1 SPTBN1 NIPSNAP2 MYO1B PTBP1 CLTC FTH1 | 6.68e-06 | 305 | 187 | 10 | 33194618 | |
| Pubmed | 8.19e-06 | 51 | 187 | 5 | 36108743 | ||
| Pubmed | 8.40e-06 | 8 | 187 | 3 | 33667029 | ||
| Pubmed | 8.40e-06 | 8 | 187 | 3 | 26993635 | ||
| Pubmed | 8.40e-06 | 8 | 187 | 3 | 11309420 | ||
| Pubmed | CK2 kinase-mediated PHF8 phosphorylation controls TopBP1 stability to regulate DNA replication. | 8.40e-06 | 8 | 187 | 3 | 33010150 | |
| Pubmed | FNBP1 ZHX3 MYH2 FAT4 HIVEP1 NEB DCUN1D4 MEPE SLC38A1 CYFIP1 CDK5RAP2 DSG4 ARHGAP45 UTY | 1.03e-05 | 638 | 187 | 14 | 31182584 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ATP5PB MYO5B GAPDH MYO9B UGGT1 MCM4 MYO1B PTBP1 SMC2 TFAM SACS CLTC SMARCA4 UTP20 HSD17B10 ASCC3 HSPA4 TOP2B | 1.17e-05 | 1024 | 187 | 18 | 24711643 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ACACA GAPDH SPTAN1 SPTBN1 MCM4 MYO1B TXLNA EIF3L CLTC HSD17B10 HSPA4 PLS3 | 1.18e-05 | 477 | 187 | 12 | 31300519 |
| Pubmed | 1.25e-05 | 9 | 187 | 3 | 31960486 | ||
| Pubmed | DOCK2 GAPDH SPTAN1 SPTBN1 PTBP1 CYFIP2 SLC38A1 CYFIP1 PTPRC CD22 CLTC HSPA4 NCKAP1L | 1.31e-05 | 565 | 187 | 13 | 20458337 | |
| Pubmed | ACACA SPTAN1 UGGT1 SPTBN1 MCM4 MYO1B CHD8 EIF3L CLTC SMARCA4 UTP20 PARN ASCC3 HSPA4 | 1.34e-05 | 653 | 187 | 14 | 22586326 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.40e-05 | 332 | 187 | 10 | 32786267 | |
| Interaction | RSPH6A interactions | 6.19e-07 | 34 | 186 | 6 | int:RSPH6A | |
| Interaction | HDAC1 interactions | FNBP1 MYH1 ZHX3 MYH2 MYH4 MYH8 HIVEP1 ACACA GAPDH ZNF273 SPTAN1 MECOM MCM4 CHD8 PPARD SMC2 RLF PHF20L1 TLE4 TET1 SMARCA4 CDK5RAP2 ZFHX3 HSD17B10 TAF1 ASCC3 HSPA4 TOP2B | 1.19e-06 | 1108 | 186 | 28 | int:HDAC1 |
| Interaction | MECOM interactions | ATP5PB MYH1 MYH2 MYH4 MYH8 MECOM MYO1B DZIP1 NEB PAF1 SMC2 CYFIP1 EIF3L CLTC SMARCA4 | 1.25e-06 | 358 | 186 | 15 | int:MECOM |
| Interaction | ATG16L1 interactions | DOCK2 PRMT8 ACACA GAPDH AVL9 TRIOBP TSC1 PTBP1 SMC2 TFAM CYFIP2 ARFGEF3 NBAS TXLNA PPP2R3A THADA CYFIP1 PTPRC CD22 EIF3L CLTC CDK5RAP2 HSD17B10 ASCC3 TBC1D23 ARHGAP45 HSPA4 TOP2B | 2.94e-06 | 1161 | 186 | 28 | int:ATG16L1 |
| Interaction | LRRC31 interactions | MYH4 ACACA MYO9B UGGT1 MYO1B PTBP1 NBAS CLTC UTP20 ASCC3 TOP2B | 3.34e-06 | 205 | 186 | 11 | int:LRRC31 |
| Interaction | DYRK1A interactions | PCYT1A MYH6 ABCA2 MYO10 SPTAN1 SPTBN1 PHYHIP TRIOBP TNS2 TSC1 LPIN3 TXLNA CLTC CDK5RAP2 PARN PEA15 GARRE1 PLS3 | 3.83e-06 | 552 | 186 | 18 | int:DYRK1A |
| Interaction | ITGB3 interactions | 4.17e-06 | 170 | 186 | 10 | int:ITGB3 | |
| Interaction | MYH1 interactions | 6.51e-06 | 76 | 186 | 7 | int:MYH1 | |
| Interaction | MYH8 interactions | 8.16e-06 | 52 | 186 | 6 | int:MYH8 | |
| Interaction | RAC3 interactions | FNBP1 FAT4 MYO10 SPTAN1 SPTBN1 TRIOBP ARFIP2 ADCY9 CYFIP2 ADD3 SLC38A1 ARHGAP5 CYFIP1 CLTC UTP20 HSD17B10 ITM2B GARRE1 | 1.81e-05 | 619 | 186 | 18 | int:RAC3 |
| Interaction | GAS7 interactions | 2.49e-05 | 38 | 186 | 5 | int:GAS7 | |
| Interaction | TSPAN33 interactions | 3.00e-05 | 65 | 186 | 6 | int:TSPAN33 | |
| Interaction | H3C1 interactions | FAT4 SET GAPDH SPTAN1 MECOM MCM4 CHD8 SRBD1 NEB PAF1 SUV39H2 RLF XIRP2 NAV3 CSTB SMARCA4 ZFHX3 PARN TAF1 ZMYM4 TOP2B AFF4 | 3.11e-05 | 901 | 186 | 22 | int:H3C1 |
| Interaction | TNNI2 interactions | 3.21e-05 | 40 | 186 | 5 | int:TNNI2 | |
| Interaction | MYH7 interactions | 4.22e-05 | 101 | 186 | 7 | int:MYH7 | |
| Interaction | ACTA1 interactions | FKBP6 NRAP MYO9B MYO10 SPTAN1 MECOM TSC1 ACTN2 CYFIP1 XPO6 CLTC FTH1 SMARCA4 | 4.29e-05 | 371 | 186 | 13 | int:ACTA1 |
| Interaction | AURKC interactions | 4.60e-05 | 43 | 186 | 5 | int:AURKC | |
| Interaction | CAPZA2 interactions | CLASP1 MYO5B SPTAN1 SPTBN1 TRIOBP MYO1B SMC2 ADD3 CYFIP1 CLTC CDK5RAP2 DSG4 CAPZA3 PLS3 | 4.84e-05 | 430 | 186 | 14 | int:CAPZA2 |
| Interaction | NUCB1 interactions | 5.09e-05 | 104 | 186 | 7 | int:NUCB1 | |
| Interaction | SMC5 interactions | MYH1 ZHX3 MYH4 HIVEP1 ACACA GAPDH TOPBP1 MCM4 CHD8 PTBP1 PAF1 TFAM CYFIP2 CYFIP1 EIF3L CLTC SMARCA4 PARN HSD17B10 TAF1 ZMYM4 TOP2B AFF4 | 5.13e-05 | 1000 | 186 | 23 | int:SMC5 |
| Interaction | RCOR1 interactions | FNBP1 HIVEP1 ACACA SPTAN1 MECOM CHD8 SMC2 RLF TET1 SMARCA4 ZFHX3 TAF1 ASCC3 HSPA4 ZMYM4 | 5.73e-05 | 494 | 186 | 15 | int:RCOR1 |
| Interaction | MYH4 interactions | 5.81e-05 | 73 | 186 | 6 | int:MYH4 | |
| Interaction | SHANK3 interactions | ATP5PB MYO5B GAPDH SPTAN1 SPTBN1 PHYHIP TSC1 ACTN2 PTBP1 CYFIP2 ARFGEF3 CYFIP1 XIRP2 ZFHX3 GNAZ | 5.99e-05 | 496 | 186 | 15 | int:SHANK3 |
| Interaction | H3-3A interactions | FNBP1 PCYT1A ZHX3 SET HIVEP1 ZNF570 TOPBP1 ADNP2 CHD8 SRBD1 SUV39H2 RLF PHF20L1 DNAJC11 SMARCA4 TAF1 ZMYM4 TOP2B AFF4 | 6.76e-05 | 749 | 186 | 19 | int:H3-3A |
| Interaction | YAP1 interactions | ACACA GAPDH CTSC SPTAN1 SPTBN1 TRIOBP MYO1B CHD8 PTBP1 PAF1 SMC2 ADD3 CYFIP1 TET1 EIF3L CLTC SMARCA4 TAF1 GNAZ ARHGAP45 HSPA4 UVRAG PLS3 ZMYM4 | 7.41e-05 | 1095 | 186 | 24 | int:YAP1 |
| Interaction | KCTD13 interactions | ATP5PB MYH6 CLASP1 MYO5B GAPDH SPTAN1 SPTBN1 PHYHIP NIPSNAP2 TSC1 ACTN2 PTBP1 TFAM CYFIP2 ADD3 GRAMD1B ARHGAP5 DZANK1 CYFIP1 SACS EIF3L CLTC FTH1 FGA SMARCA4 GNAZ HSPA4 PLS3 | 8.17e-05 | 1394 | 186 | 28 | int:KCTD13 |
| Interaction | RND1 interactions | FNBP1 SPTAN1 SPTBN1 DZIP1 ARFIP2 ADCY9 ADD3 SLC38A1 ARHGAP5 CLTC | 1.00e-04 | 246 | 186 | 10 | int:RND1 |
| Interaction | LGALS9 interactions | ABCA2 ACACA GAPDH SPTAN1 SPTBN1 PTBP1 SMC2 SLC38A1 CYFIP1 EIF3L CLTC CSTB HSD17B10 ASCC3 PLS3 TOP2B | 1.17e-04 | 588 | 186 | 16 | int:LGALS9 |
| Interaction | STK4 interactions | 1.17e-04 | 159 | 186 | 8 | int:STK4 | |
| Interaction | WHAMMP3 interactions | 1.20e-04 | 119 | 186 | 7 | int:WHAMMP3 | |
| Interaction | ARX interactions | 1.21e-04 | 28 | 186 | 4 | int:ARX | |
| Interaction | SUMO2 interactions | SET GAPDH SPTAN1 SPTBN1 MCM4 CHD8 PTBP1 PAF1 SMC2 CLTC SMARCA4 PARN HSD17B10 TAF1 ZMYM4 TOP2B | 1.24e-04 | 591 | 186 | 16 | int:SUMO2 |
| Interaction | FKBP6 interactions | 1.45e-04 | 86 | 186 | 6 | int:FKBP6 | |
| Interaction | FBXO42 interactions | HIVEP1 CLASP1 CENPE MYO9B TSC1 ARFGEF3 CYFIP1 CLTC HSD17B10 GARRE1 | 1.53e-04 | 259 | 186 | 10 | int:FBXO42 |
| Interaction | TPM1 interactions | 1.73e-04 | 263 | 186 | 10 | int:TPM1 | |
| Interaction | ACTN2 interactions | 1.93e-04 | 171 | 186 | 8 | int:ACTN2 | |
| Interaction | COIL interactions | PRMT8 HIVEP1 MYO5B MYO10 CHD8 ACTN2 SRBD1 PAF1 RLF UTP20 HSD17B10 TAF1 TOP2B AFF4 ZFP62 | 1.95e-04 | 552 | 186 | 15 | int:COIL |
| Interaction | NCKAP1 interactions | 1.99e-04 | 218 | 186 | 9 | int:NCKAP1 | |
| Interaction | HSPB8 interactions | 2.01e-04 | 172 | 186 | 8 | int:HSPB8 | |
| Interaction | TMEM260 interactions | 2.07e-04 | 13 | 186 | 3 | int:TMEM260 | |
| Interaction | LATS1 interactions | ATP5PB MYH1 MYH2 MYH4 MYH6 MYH8 SPTAN1 SPTBN1 MYO1B NEB XIRP2 DNAJC11 CDK5RAP2 | 2.35e-04 | 440 | 186 | 13 | int:LATS1 |
| Interaction | PPP1R9B interactions | ATP5PB MYH4 GAPDH SPTAN1 SPTBN1 PHYHIP MECOM MYO1B ACTN2 PDE10A CYFIP2 CYFIP1 CLTC GNAZ PHYHIPL HSPA4 | 2.38e-04 | 626 | 186 | 16 | int:PPP1R9B |
| Interaction | KLF3 interactions | 2.77e-04 | 228 | 186 | 9 | int:KLF3 | |
| Interaction | STK3 interactions | 2.85e-04 | 181 | 186 | 8 | int:STK3 | |
| Interaction | RHOH interactions | FNBP1 SPTAN1 SPTBN1 TRIOBP NIPSNAP2 TSC1 ADCY9 ADD3 SLC38A1 CYFIP1 CLTC HSD17B10 ITM2B TOP2B | 2.99e-04 | 512 | 186 | 14 | int:RHOH |
| Cytoband | 9q34 | 7.19e-05 | 54 | 187 | 4 | 9q34 | |
| GeneFamily | Myosin heavy chains | 3.23e-08 | 15 | 119 | 5 | 1098 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.19e-04 | 15 | 119 | 3 | 529 | |
| GeneFamily | LIM domain containing | 6.14e-04 | 59 | 119 | 4 | 1218 | |
| GeneFamily | EF-hand domain containing|Spectrins | 8.83e-04 | 7 | 119 | 2 | 1113 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZHX3 HIVEP1 ZNF273 ZNF570 ADNP2 MECOM RLF ZNF341 ZNF286B ZNF432 ZFHX3 ZNF614 ZFP62 | 8.92e-04 | 718 | 119 | 13 | 28 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZHX3 HIVEP1 CLASP1 CENPE AVL9 MYO9B MYO10 TOPBP1 MECOM MYO1B DCUN1D4 ADCY9 RLF NBAS PPP2R3A SACS XPO6 TLE4 MKLN1 NAV3 UTP20 ZFHX3 PARN ASCC3 UVRAG GARRE1 ZMYM4 | 8.76e-11 | 856 | 186 | 27 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZHX3 HIVEP1 CLASP1 CENPE MYO10 TOPBP1 MYO1B DCUN1D4 PPP2R3A TLE4 MKLN1 PARN ASCC3 UVRAG ZMYM4 | 1.32e-06 | 466 | 186 | 15 | M13522 |
| Coexpression | GSE27786_CD4_VS_CD8_TCELL_DN | 1.70e-06 | 199 | 186 | 10 | M4821 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | DOCK2 CLASP1 CENPE MYO9B SPTAN1 SPTBN1 TSC1 ARFIP2 ARHGAP5 CDK5RAP2 | 1.70e-06 | 199 | 186 | 10 | M5893 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CCDC91 FNBP1 CENPE MYO10 ESRRG DZIP1 SMC2 ADD3 RLF ARHGAP5 PPP2R3A PHF20L1 SACS CDK5RAP2 ZDHHC11 PLS3 TOP2B | 4.83e-06 | 656 | 186 | 17 | M18979 |
| Coexpression | GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP | 1.08e-05 | 194 | 186 | 9 | M3540 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.09e-05 | 20 | 186 | 4 | M1123 | |
| Coexpression | GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP | 1.18e-05 | 196 | 186 | 9 | M3553 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP | 1.22e-05 | 197 | 186 | 9 | M5295 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.34e-05 | 21 | 186 | 4 | MM1102 | |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP | 1.38e-05 | 200 | 186 | 9 | M8320 | |
| Coexpression | GSE3982_DC_VS_NKCELL_UP | 1.38e-05 | 200 | 186 | 9 | M5478 | |
| Coexpression | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION | 2.28e-05 | 48 | 186 | 5 | M16123 | |
| Coexpression | NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 4.20e-05 | 89 | 186 | 6 | M41173 | |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_F | 4.45e-05 | 55 | 186 | 5 | M2043 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 4.59e-05 | 233 | 186 | 9 | M13273 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | FNBP1 ZHX3 CTSC SPTAN1 SPTBN1 MCM4 PDE10A FRMD4B ADCY9 LDB3 PTPRC PHF20L1 SACS SMARCA4 ZDHHC11 CTSK PEA15 | 5.17e-05 | 790 | 186 | 17 | M12490 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | MYO9B ESRRG TRIOBP MCM4 PPARD PTBP1 ADCY9 ADM NBAS THADA XPO6 COMMD10 HSPA4 NCKAP1L | 5.75e-05 | 567 | 186 | 14 | M16909 |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_DN | 7.20e-05 | 192 | 186 | 8 | M9983 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8 | 7.38e-05 | 12 | 186 | 3 | M5304 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 7.89e-05 | 250 | 186 | 9 | M11318 | |
| Coexpression | DANG_REGULATED_BY_MYC_DN | 8.14e-05 | 251 | 186 | 9 | M2310 | |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP | 8.31e-05 | 196 | 186 | 8 | M3351 | |
| Coexpression | GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN | 8.61e-05 | 197 | 186 | 8 | M8303 | |
| Coexpression | GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP | 8.61e-05 | 197 | 186 | 8 | M7264 | |
| Coexpression | GSE12366_GC_BCELL_VS_PLASMA_CELL_UP | 8.61e-05 | 197 | 186 | 8 | M3166 | |
| Coexpression | GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_DN | 9.24e-05 | 199 | 186 | 8 | M9543 | |
| Coexpression | GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP | 9.57e-05 | 200 | 186 | 8 | M5069 | |
| Coexpression | HALLMARK_MYOGENESIS | 9.57e-05 | 200 | 186 | 8 | M5909 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP | 9.57e-05 | 200 | 186 | 8 | M5706 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP | 9.57e-05 | 200 | 186 | 8 | M4497 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | MYO5B MYO10 CTSC SPTAN1 SPTBN1 TRIOBP NIPSNAP2 SLC38A1 ADM FRMD4A PPP2R3A CYFIP1 SH2D4A CCDC198 PTPRC FTH1 TSPAN6 FGA CSTB PEA15 PLS3 TOP2B | 1.11e-04 | 1276 | 186 | 22 | M39173 |
| Coexpression | TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN | CCDC91 DOCK2 CTSC DCUN1D4 CYFIP2 SLC38A1 CEP68 PTPRC TSPAN6 NCKAP1L | 1.23e-04 | 327 | 186 | 10 | M2351 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.26e-04 | 208 | 186 | 8 | M39233 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | NPR3 HIVEP1 NEBL MYO10 TNS2 MYO1B PDE10A ARFGEF3 ADM ARHGAP5 TMTC1 SH2D4A PTPRC PHF20L1 TLE4 SLITRK6 GARRE1 | 1.33e-04 | 854 | 186 | 17 | M1533 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | FAT4 SET SPTBN1 ADNP2 TRIOBP MYO1B DZIP1 TXLNA CLTC CDK5RAP2 ZFHX3 TAF1 | 1.36e-04 | 467 | 186 | 12 | M1347 |
| Coexpression | GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN | ZHX3 MYO9B SPTBN1 TRIOBP CYFIP2 ADM UTP20 CTSK PEA15 ZNF614 ZMYM4 NCKAP1L | 1.47e-04 | 471 | 186 | 12 | M19016 |
| Coexpression | TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN | CCDC91 DOCK2 CTSC DCUN1D4 CYFIP2 SLC38A1 CEP68 PTPRC TSPAN6 NCKAP1L | 1.57e-04 | 337 | 186 | 10 | MM1069 |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | PCYT1A MYO10 HIPK1 SPTBN1 XDH PPAT DUS3L TXLNA XPO6 SMARCA4 HSPA4 | 1.71e-04 | 408 | 186 | 11 | M11891 |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | SET CENPE ESRRG TRMT11 MCM4 PPAT TFAM ADD3 ARHGAP5 PPP2R3A EIF3L ZFHX3 ZFP62 | 1.78e-04 | 555 | 186 | 13 | M2343 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | FAT4 SET SPTBN1 ADNP2 TRIOBP MYO1B DZIP1 TXLNA CLTC CDK5RAP2 ZFHX3 TAF1 | 1.89e-04 | 484 | 186 | 12 | MM999 |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | PCYT1A MYO10 HIPK1 SPTBN1 XDH PPAT DUS3L TXLNA XPO6 SMARCA4 HSPA4 | 1.98e-04 | 415 | 186 | 11 | MM1028 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | NPR3 HIVEP1 NEBL MYO10 TNS2 MYO1B PDE10A ARFGEF3 ADM ARHGAP5 TMTC1 SH2D4A PTPRC PHF20L1 TLE4 SLITRK6 GARRE1 | 2.10e-04 | 888 | 186 | 17 | MM1018 |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 2.28e-04 | 171 | 186 | 7 | M39234 | |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP | 2.28e-04 | 171 | 186 | 7 | M5655 | |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP | 2.91e-04 | 178 | 186 | 7 | M6326 | |
| Coexpression | EPPERT_HSC_R | 2.99e-04 | 127 | 186 | 6 | M19231 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | CCDC91 SET MYO5B SPTBN1 MECOM ADD3 SLC38A1 CD22 EIF3L FGA TAF1 PLS3 ZNF614 | 3.06e-04 | 587 | 186 | 13 | M40869 |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | FNBP1 SET NEBL PHYHIP MYO1B ADD3 ADM ARHGAP5 TLE4 PLS3 TOP2B | 3.07e-04 | 437 | 186 | 11 | M4665 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | NDNF ABCA2 MYO5B SPTBN1 APBA1 EFCAB14 DZIP1 FRMD4B ADCY9 CYFIP2 ADD3 CREBRF ARHGAP5 NAV3 ZFHX3 TBC1D23 PHYHIPL CTSK HSPA4 | 3.34e-04 | 1102 | 186 | 19 | M2369 |
| Coexpression | YAGI_AML_WITH_T_8_21_TRANSLOCATION | 3.45e-04 | 372 | 186 | 10 | M19261 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | TRHDE SET NEBL CENPE TOPBP1 MCM4 TSC1 PTBP1 SRBD1 ARFIP2 TFAM ADCY9 ADD3 TMEM260 CEP68 THADA TSPAN6 CDK5RAP2 | 3.79e-04 | 1023 | 186 | 18 | M17122 |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | 4.20e-04 | 313 | 186 | 9 | M39128 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | NDNF ABCA2 MYO5B SPTBN1 APBA1 EFCAB14 DZIP1 FRMD4B ADCY9 CYFIP2 ADD3 CREBRF ARHGAP5 NAV3 ZFHX3 TBC1D23 PHYHIPL CTSK HSPA4 | 4.26e-04 | 1124 | 186 | 19 | MM1070 |
| Coexpression | CYCLIN_D1_KE_.V1_DN | 4.45e-04 | 191 | 186 | 7 | M2647 | |
| Coexpression | P53_DN.V1_DN | 4.88e-04 | 194 | 186 | 7 | M2697 | |
| Coexpression | EGUCHI_CELL_CYCLE_RB1_TARGETS | 4.90e-04 | 22 | 186 | 3 | M4455 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_DN | 5.04e-04 | 195 | 186 | 7 | M9813 | |
| Coexpression | WINTER_HYPOXIA_DN | 5.09e-04 | 52 | 186 | 4 | M2683 | |
| Coexpression | LAKE_ADULT_KIDNEY_C18_COLLECTING_DUCT_PRINCIPAL_CELLS_MEDULLA | 5.15e-04 | 322 | 186 | 9 | M39237 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN | 5.19e-04 | 196 | 186 | 7 | M8420 | |
| Coexpression | GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP | 5.19e-04 | 196 | 186 | 7 | M7562 | |
| Coexpression | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 | 5.35e-04 | 197 | 186 | 7 | M12824 | |
| Coexpression | GSE22886_TH1_VS_TH2_12H_ACT_DN | 5.35e-04 | 197 | 186 | 7 | M4509 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 5.35e-04 | 197 | 186 | 7 | M9862 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 5.35e-04 | 197 | 186 | 7 | M7403 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | DOCK2 MYH6 SET ZNF273 HIPK1 TOPBP1 NIPSNAP2 ADD3 CEP68 PTPRC PLCL2 HSPA4 TOP2B NCKAP1L | 5.37e-04 | 705 | 186 | 14 | M1410 |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 5.52e-04 | 198 | 186 | 7 | M7610 | |
| Coexpression | GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN | 5.52e-04 | 198 | 186 | 7 | M7605 | |
| Coexpression | GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP | 5.52e-04 | 198 | 186 | 7 | M5580 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP | 5.68e-04 | 199 | 186 | 7 | M8107 | |
| Coexpression | GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP | 5.68e-04 | 199 | 186 | 7 | M9853 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP | 5.68e-04 | 199 | 186 | 7 | M7712 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN | 5.68e-04 | 199 | 186 | 7 | M9253 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN | 5.68e-04 | 199 | 186 | 7 | M3175 | |
| Coexpression | GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN | 5.85e-04 | 200 | 186 | 7 | M9486 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN | 5.85e-04 | 200 | 186 | 7 | M9321 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP | 5.85e-04 | 200 | 186 | 7 | M4590 | |
| Coexpression | GSE22886_CTRL_VS_LPS_24H_DC_UP | 5.85e-04 | 200 | 186 | 7 | M4518 | |
| Coexpression | GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP | 5.85e-04 | 200 | 186 | 7 | M3529 | |
| Coexpression | GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN | 5.85e-04 | 200 | 186 | 7 | M8311 | |
| Coexpression | GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP | 5.85e-04 | 200 | 186 | 7 | M8308 | |
| Coexpression | GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_DN | 5.85e-04 | 200 | 186 | 7 | M8325 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP | 5.85e-04 | 200 | 186 | 7 | M9742 | |
| Coexpression | GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN | 5.85e-04 | 200 | 186 | 7 | M8543 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_CULTURE_UP | 5.85e-04 | 200 | 186 | 7 | M7301 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN | 5.85e-04 | 200 | 186 | 7 | M7143 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 5.85e-04 | 200 | 186 | 7 | M7518 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_16H_BMDC_DN | 5.85e-04 | 200 | 186 | 7 | M3819 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 5.85e-04 | 200 | 186 | 7 | M7417 | |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP | 5.85e-04 | 200 | 186 | 7 | M7776 | |
| Coexpression | GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP | 5.85e-04 | 200 | 186 | 7 | M7841 | |
| Coexpression | GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_DN | 5.85e-04 | 200 | 186 | 7 | M9049 | |
| Coexpression | LEE_DIFFERENTIATING_T_LYMPHOCYTE | 6.03e-04 | 201 | 186 | 7 | M2200 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | CLASP1 HIPK1 SPTBN1 TFAM GRAMD1B CEP68 PHF20L1 TLE4 MKLN1 ASCC3 AFF4 | 6.06e-04 | 474 | 186 | 11 | M40991 |
| Coexpression | KAUFFMANN_DNA_REPLICATION_GENES | 6.28e-04 | 146 | 186 | 6 | M9372 | |
| Coexpression | GOLUB_ALL_VS_AML_UP | 6.38e-04 | 24 | 186 | 3 | M4275 | |
| Coexpression | BENPORATH_PROLIFERATION | 6.51e-04 | 147 | 186 | 6 | M2114 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | NDNF PRMT8 MYO5B CENPE PDSS1 SPTAN1 PDE10A SMC2 CYFIP2 RLF PHF20L1 CEP83 DISP3 ASCC3 PHYHIPL HSPA4 | 1.38e-05 | 532 | 181 | 16 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.46e-05 | 72 | 181 | 6 | gudmap_developingKidney_e13.5_podocyte cells_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | PCYT1A MYH8 FKBP6 SPTBN1 TSC1 CHD8 TEX15 PDE10A SMC2 FRMD4B ADD3 RLF CREBRF ARHGAP5 SACS PHYHIPL GARRE1 ZFP62 CCDC158 | 3.74e-05 | 776 | 181 | 19 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.13e-05 | 192 | 181 | 9 | gudmap_kidney_adult_RenCorpuscGlomer_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.70e-05 | 151 | 181 | 8 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | NDNF SET CENPE PDSS1 HIPK1 CTSC MYO1B TSC1 EFCAB14 DZIP1 SMC2 SUV39H2 ARHGAP5 FRMD4A DZANK1 XPO6 TET1 PLCL2 CEP83 TSPAN6 ZFHX3 SLITRK6 HSPA4 TOP2B ZFP62 | 6.39e-05 | 1252 | 181 | 25 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.26e-05 | 210 | 181 | 9 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | FAM184A SET ABCA2 PRMT8 NEBL CLASP1 CENPE MYO10 SPTAN1 TRIOBP TSC1 AASDH SMC2 DCUN1D4 SUV39H2 CYFIP2 SLC38A1 CREBRF DZANK1 TMTC1 TLE4 CEP83 PHYHIPL PEA15 HSPA4 TOP2B | 1.03e-04 | 1370 | 181 | 26 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | TRHDE FAM184A ABCA2 PRMT8 MYO5B CENPE MYO10 MECOM ACTN2 PDE10A PPAT DMBX1 CYFIP2 SLC38A1 DNAJC11 CEP83 SMARCA4 UTP20 PHYHIPL HSPA4 TOP2B | 1.11e-04 | 989 | 181 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | MYH8 FKBP6 TSC1 CHD8 TEX15 SMC2 FRMD4B RLF SACS PHYHIPL ZFP62 CCDC158 | 1.13e-04 | 382 | 181 | 12 | gudmap_developingGonad_e14.5_ ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | PCYT1A FKBP6 CLASP1 SPTBN1 TSC1 CHD8 TEX15 PDE10A NEB SMC2 CCDC141 FRMD4B ADD3 RLF ARHGAP5 SACS ZFP62 CCDC158 | 1.23e-04 | 778 | 181 | 18 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | FAM184A NPR3 NAALAD2 MYO10 HIPK1 SPTAN1 SPTBN1 XDH MECOM TNS2 MYO1B PDE10A CREBRF SH2D4A ITM2B PEA15 UVRAG PLS3 CCDC152 | 1.73e-04 | 872 | 181 | 19 | gudmap_kidney_adult_Mesangium_Meis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NDNF NPR3 NAALAD2 CLASP1 SPTBN1 TSC1 CHD8 PDE10A SMC2 FRMD4B ADD3 RLF TET1 SMARCA4 ZFHX3 CTSK UTY ZFP62 | 1.77e-04 | 801 | 181 | 18 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500 | 2.29e-04 | 101 | 181 | 6 | gudmap_developingGonad_e14.5_ ovary_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | NDNF NAALAD2 CLASP1 SPTBN1 CHD8 PDE10A SMC2 FRMD4B ADD3 RLF TET1 CTSK | 2.32e-04 | 413 | 181 | 12 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | NDNF FAM184A SET ABCA2 PRMT8 NEBL GAPDH CENPE MYO10 TRIOBP MCM4 PPAT SMC2 SUV39H2 CYFIP2 SLC38A1 ARHGAP5 TLE4 TET1 CEP83 UTP20 ARHGAP45 PHYHIPL HSPA4 ZMYM4 | 2.63e-04 | 1371 | 181 | 25 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | ZHX3 FAT4 NPR3 NAALAD2 XDH MECOM DZIP1 PDE10A CCDC141 FRMD4A TMTC1 CTSK | 2.76e-04 | 421 | 181 | 12 | gudmap_developingKidney_e15.5_Peripheral blastema_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | FAT4 NPR3 PAMR1 MYO10 CTSC SPTAN1 SPTBN1 MECOM MYO1B FRMD4A PTPRC SACS TSPAN6 NAV3 PEA15 UVRAG GARRE1 NCKAP1L | 2.77e-04 | 831 | 181 | 18 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | MYH2 NAALAD2 FKBP6 CENPE MYO10 SPTBN1 XDH TSC1 CHD8 TEX15 NEB SMC2 CCDC141 FRMD4B ADD3 ADH4 RLF | 3.30e-04 | 770 | 181 | 17 | gudmap_developingGonad_P2_ovary_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TRHDE MYH1 FAT4 ABCA13 RGS22 APOB NEB ARFGEF3 LDB3 XIRP2 SCN9A NAV3 DISP3 | 1.13e-12 | 184 | 187 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TRHDE MYH1 FAT4 ABCA13 RGS22 APOB NEB ARFGEF3 LDB3 XIRP2 SCN9A NAV3 DISP3 | 1.13e-12 | 184 | 187 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TRHDE MYH1 FAT4 ABCA13 RGS22 APOB NEB ARFGEF3 LDB3 XIRP2 SCN9A NAV3 DISP3 | 1.13e-12 | 184 | 187 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | DOCK2 FNBP1 MYO9B CTSC PPARD GRAMD1B FRMD4A PTPRC PLCL2 FTH1 DDX60L NCKAP1L | 5.13e-11 | 198 | 187 | 12 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | DOCK2 NRAP NEBL ACTN2 CCDC141 FRMD4B LDB3 XIRP2 DDX60L NCKAP1L | 2.88e-09 | 170 | 187 | 10 | 4232fe937909f93d3736988c707b8f95ce993398 |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | DOCK2 MYO9B CTSC PPARD GRAMD1B FRMD4A FTH1 CSTB DDX60L NCKAP1L | 1.08e-08 | 195 | 187 | 10 | 55e25f702af19146a161861cfd15f40bbda1dc35 |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | DOCK2 FNBP1 MYO9B CTSC FRMD4A PTPRC PLCL2 FTH1 DDX60L NCKAP1L | 1.19e-08 | 197 | 187 | 10 | f18807124b91310fcd84238484a80ecdba684679 |
| ToppCell | Immune|World / Lineage, Cell type, age group and donor | DOCK2 FNBP1 MYO9B CTSC GRAMD1B PTPRC PLCL2 FTH1 DDX60L NCKAP1L | 1.25e-08 | 198 | 187 | 10 | 65681b54d13c6997bd90a1c2a12314a80e964fe3 |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-08 | 172 | 187 | 9 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-08 | 172 | 187 | 9 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.40e-08 | 177 | 187 | 9 | 3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | FAM184A PRMT8 ESRRG MECOM DZIP1 CYFIP2 ARFGEF3 PPP2R3A DNAJC11 | 7.39e-08 | 180 | 187 | 9 | 9e09b3dfe344b5d50520711513d389865d73a861 |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 8.13e-08 | 182 | 187 | 9 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ZHX3 FAM184A ESRRG MECOM DZIP1 CYFIP2 ARFGEF3 PPP2R3A DNAJC11 | 9.34e-08 | 185 | 187 | 9 | 03f64a7132b13a01ba47187e0e15c13ac88f7cb2 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ZHX3 FAM184A ESRRG MECOM DZIP1 CYFIP2 ARFGEF3 PPP2R3A DNAJC11 | 9.78e-08 | 186 | 187 | 9 | 1850583d23903d08226aeb0edb3e07b0994330e4 |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.02e-07 | 187 | 187 | 9 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-07 | 188 | 187 | 9 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.12e-07 | 189 | 187 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.17e-07 | 190 | 187 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.28e-07 | 192 | 187 | 9 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.40e-07 | 194 | 187 | 9 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Immune-alveolar_macrophage_(MARCO_positive)|World / Lineage, Cell type, age group and donor | 1.46e-07 | 195 | 187 | 9 | f92114ef995e690a3bedc62c89c5fd6773d0d9f7 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.46e-07 | 195 | 187 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D231|Adult / Lineage, Cell type, age group and donor | 1.67e-07 | 198 | 187 | 9 | 79a415e19cedde13a88f5043d71557363f102322 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-07 | 199 | 187 | 9 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 1.81e-07 | 200 | 187 | 9 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-07 | 164 | 187 | 8 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.52e-07 | 167 | 187 | 8 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-07 | 170 | 187 | 8 | 626c12b9a51218f72ee32afb5fd5d4b075025d75 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-07 | 170 | 187 | 8 | 31daac8696ae8c021c0302d3b30dd8194054b3e7 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-07 | 170 | 187 | 8 | ca88dc0b7a6960facb7c4d3c0f4795431a0a43d2 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-07 | 170 | 187 | 8 | b6882665a27c78a63f3b4a2a8806c8438a98e407 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-07 | 172 | 187 | 8 | 1565f38266891c3acf49778838de134c5dee5460 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.21e-07 | 173 | 187 | 8 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-07 | 174 | 187 | 8 | 4a6e04b4f12b87c15fa1409989cbe32c43736369 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.21e-07 | 176 | 187 | 8 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 8.57e-07 | 177 | 187 | 8 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.33e-07 | 179 | 187 | 8 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.01e-06 | 181 | 187 | 8 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.06e-06 | 182 | 187 | 8 | e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 182 | 187 | 8 | edfc598b7199ca1d8a399b264ab863c299b1eede | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 182 | 187 | 8 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.20e-06 | 185 | 187 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 185 | 187 | 8 | 9245c322aae8bb9065d50dada198a5ee143a3444 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.24e-06 | 186 | 187 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 186 | 187 | 8 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 186 | 187 | 8 | 4dafc215c42e7949f932a3627359c107943b5d6b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.30e-06 | 187 | 187 | 8 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-06 | 187 | 187 | 8 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 188 | 187 | 8 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.35e-06 | 188 | 187 | 8 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 188 | 187 | 8 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.40e-06 | 189 | 187 | 8 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 189 | 187 | 8 | d2b008f98739c6af7ee63b643011a240db20e4d8 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 189 | 187 | 8 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 189 | 187 | 8 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.40e-06 | 189 | 187 | 8 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.46e-06 | 190 | 187 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 191 | 187 | 8 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.52e-06 | 191 | 187 | 8 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.52e-06 | 191 | 187 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 191 | 187 | 8 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-06 | 192 | 187 | 8 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 1.64e-06 | 193 | 187 | 8 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.64e-06 | 193 | 187 | 8 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.64e-06 | 193 | 187 | 8 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.64e-06 | 193 | 187 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-06 | 193 | 187 | 8 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 193 | 187 | 8 | b397c14ac1e34c6be3f25d4417d200bc518d3048 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-06 | 194 | 187 | 8 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-06 | 194 | 187 | 8 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-06 | 194 | 187 | 8 | 69cf7c989ac355c459db13f9d4267b55adc3c174 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.77e-06 | 195 | 187 | 8 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.77e-06 | 195 | 187 | 8 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.77e-06 | 195 | 187 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 195 | 187 | 8 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-06 | 196 | 187 | 8 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.91e-06 | 197 | 187 | 8 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-06 | 197 | 187 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.99e-06 | 198 | 187 | 8 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.99e-06 | 198 | 187 | 8 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 199 | 187 | 8 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-06 | 199 | 187 | 8 | cbd423c31d75f6d2f5ae85d2241641fcbe630b81 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 199 | 187 | 8 | 7ee2805fd9143eba11bf6832267b62189683608b | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-06 | 199 | 187 | 8 | 980b10b81ee9dc952e3be25bd294201ce5a4ca8b | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.14e-06 | 200 | 187 | 8 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.14e-06 | 200 | 187 | 8 | 58a7ece7dfdf6c46f2a50cbcb580574dec14c748 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.14e-06 | 200 | 187 | 8 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.14e-06 | 200 | 187 | 8 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-06 | 200 | 187 | 8 | ed785a6d08ca2b350dc3307b587eadfb2886d1f9 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.14e-06 | 200 | 187 | 8 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.14e-06 | 200 | 187 | 8 | b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.14e-06 | 200 | 187 | 8 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 6.15e-06 | 164 | 187 | 7 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-06 | 164 | 187 | 7 | b77995958c938e10a526118f75d78cee72e0b207 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.40e-06 | 165 | 187 | 7 | 731147b4337fd0de4383dc8170b4f9ccd98caec6 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-06 | 165 | 187 | 7 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 7.20e-06 | 168 | 187 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.78e-06 | 170 | 187 | 7 | 92e0873f618b2fa60c4d555b10f234d5cbcf3325 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.78e-06 | 170 | 187 | 7 | c181991f933b779f99afc3782f292306f209e2ac | |
| Drug | clenbuterol | MYH1 MYH2 MYH4 MYH6 MYH8 MYO5B MYO9B MYO10 ESRRG MYO1B PAF1 ADCY9 SCN9A | 1.54e-10 | 142 | 185 | 13 | CID000002783 |
| Drug | formycin triphosphate | 2.88e-10 | 51 | 185 | 9 | CID000122274 | |
| Drug | purealin | 9.60e-10 | 58 | 185 | 9 | CID006419303 | |
| Drug | S-(-)-Etomoxir | 9.04e-09 | 100 | 185 | 10 | CID000060765 | |
| Drug | eye gene | MYH1 MYH2 MYH4 MYH6 NPR1 MYH8 NPR3 ACACA MYO5B MYO9B MYO10 MYO1B PAF1 ADCY9 ADM HSPA4 PLS3 | 9.85e-09 | 369 | 185 | 17 | CID000004782 |
| Drug | blebbistatin | 3.81e-08 | 116 | 185 | 10 | CID003476986 | |
| Drug | B0683 | 4.14e-08 | 117 | 185 | 10 | CID006398969 | |
| Drug | trifluoperazine | MYH1 MYH2 MYH4 MYH6 MYH8 ACACA MYO5B MYO9B MYO10 SPTAN1 SPTBN1 XDH MYO1B ADCY9 PLS3 | 7.09e-08 | 324 | 185 | 15 | CID000005566 |
| Drug | NSC339663 | MYH1 MYH2 MYH4 MYH6 MYH8 MYO5B MYO9B MYO10 CTSC TRIOBP MYO1B CLTC PLS3 | 1.44e-07 | 250 | 185 | 13 | CID000003892 |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | HIVEP1 CLASP1 CENPE AVL9 MYO10 MECOM DCUN1D4 ADCY9 TLE4 CDK5RAP2 UVRAG | 1.93e-07 | 174 | 185 | 11 | 7530_DN |
| Drug | AC1L1IZ2 | MYH1 MYH2 MYH4 MYH6 NPR1 MYH8 MYO5B MYO9B MYO10 MYO1B TSC1 ADCY9 PLS3 TOP2B | 2.09e-07 | 304 | 185 | 14 | CID000004795 |
| Drug | K-Cl | MYH1 MYH2 MYH4 MYH6 NPR1 MYH8 NPR3 MYO5B GAPDH MYO9B MYO10 ESRRG MYO1B AASDH PPAT PAF1 ADCY9 PLS3 | 9.46e-07 | 567 | 185 | 18 | CID000004873 |
| Drug | fast white | 1.09e-06 | 42 | 185 | 6 | CID000024008 | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; PC3; HG-U133A | FNBP1 SET ACACA TOPBP1 TRMT11 EFCAB14 PTBP1 TSPAN6 COMMD10 TOP2B | 5.33e-06 | 198 | 185 | 10 | 1900_DN |
| Drug | 4-chloroaniline | 6.36e-06 | 202 | 185 | 10 | CID000007812 | |
| Drug | pyrophosphate | PCYT1A MYH1 MYH2 MYH4 MYH6 NPR1 MYH8 NPR3 MYO5B GAPDH PDSS1 MYO9B MYO10 MYO1B PPAT ADCY9 TMTC1 TAF1 | 6.94e-06 | 654 | 185 | 18 | CID000001023 |
| Drug | MgCl2 | MYH1 MYH2 MYH4 MYH6 MYH8 MYO5B MYO9B MYO10 SPTAN1 SPTBN1 MYO1B ADCY9 PLS3 | 7.00e-06 | 354 | 185 | 13 | CID000024584 |
| Drug | SM-2 | 7.05e-06 | 87 | 185 | 7 | CID000486033 | |
| Drug | NSC107658 | MYH1 MYH2 MYH4 MYH6 MYH8 MYO5B MYO9B MYO10 SPTAN1 MYO1B FGA PLS3 | 8.25e-06 | 306 | 185 | 12 | CID000002919 |
| Drug | Chloroprene | NDNF FAT4 NPR3 PRMT8 NEBL MYO10 CTSC SPTBN1 TOPBP1 NIPSNAP2 XDH MYO1B CCDC141 ADD3 KLRK1 CREBRF ADM ARHGAP5 TMTC1 LDB3 SH2D4A PTPRC PHF20L1 CD22 TET1 SMARCA4 AFF4 | 1.31e-05 | 1348 | 185 | 27 | ctd:D002737 |
| Drug | AC1NRBPQ | 1.67e-05 | 137 | 185 | 8 | CID005288569 | |
| Drug | N-ethylmaleimide | MYH1 MYH2 MYH4 MYH6 NPR1 MYH8 MYO5B MYO9B MYO10 SPTAN1 SPTBN1 MYO1B ADCY9 CLTC HSPA4 | 1.99e-05 | 511 | 185 | 15 | CID000004362 |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 2.75e-05 | 191 | 185 | 9 | 4279_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; HL60; HG-U133A | 2.99e-05 | 193 | 185 | 9 | 1412_DN | |
| Drug | AC1N9ZZC | 3.06e-05 | 149 | 185 | 8 | CID004369374 | |
| Drug | hydroxyrubicin | 3.31e-05 | 23 | 185 | 4 | CID000072398 | |
| Drug | isoproterenol | MYH1 MYH2 MYH4 MYH6 NPR1 MYH8 NPR3 MYO5B MYO9B MYO10 MYO1B PDE10A PAF1 ADCY9 ADM SCN9A PLS3 | 3.48e-05 | 669 | 185 | 17 | CID000003779 |
| Drug | Roxarsone [121-19-7]; Up 200; 15.2uM; PC3; HT_HG-U133A | 3.51e-05 | 197 | 185 | 9 | 5051_UP | |
| Drug | 5255229; Down 200; 13uM; MCF7; HT_HG-U133A_EA | 3.65e-05 | 198 | 185 | 9 | 833_DN | |
| Drug | Cefoperazone dihydrate; Up 200; 5.8uM; MCF7; HT_HG-U133A | 3.65e-05 | 198 | 185 | 9 | 5424_UP | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Up 200; 21uM; PC3; HT_HG-U133A | 3.80e-05 | 199 | 185 | 9 | 5050_UP | |
| Drug | Esculetin [305-01-1]; Down 200; 22.4uM; MCF7; HT_HG-U133A | 3.80e-05 | 199 | 185 | 9 | 6499_DN | |
| Drug | Trimethadione [127-48-0]; Up 200; 28uM; PC3; HT_HG-U133A | 3.95e-05 | 200 | 185 | 9 | 4086_UP | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 3.95e-05 | 200 | 185 | 9 | 5921_DN | |
| Drug | verapamil | MYH1 MYH2 MYH4 MYH6 MYH8 ABCA2 MYO5B ABCA13 APOB PAF1 ADCY9 KCNG4 SCN9A TOP2B | 5.07e-05 | 490 | 185 | 14 | CID000002520 |
| Drug | carvedilol | 5.32e-05 | 161 | 185 | 8 | CID000002585 | |
| Drug | 2bq7 | 6.71e-05 | 123 | 185 | 7 | CID006540267 | |
| Drug | AC1LADJ6 | 9.51e-05 | 130 | 185 | 7 | CID000486032 | |
| Drug | papaverine | 9.94e-05 | 176 | 185 | 8 | CID000004680 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.08e-09 | 10 | 182 | 5 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.08e-09 | 10 | 182 | 5 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.08e-09 | 10 | 182 | 5 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.08e-09 | 10 | 182 | 5 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.08e-09 | 10 | 182 | 5 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.08e-09 | 10 | 182 | 5 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.08e-09 | 10 | 182 | 5 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.08e-09 | 10 | 182 | 5 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 6.46e-09 | 12 | 182 | 5 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 6.46e-09 | 12 | 182 | 5 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.04e-08 | 13 | 182 | 5 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.41e-08 | 15 | 182 | 5 | DOID:0050646 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.88e-07 | 71 | 182 | 7 | DOID:0050700 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 5.02e-07 | 48 | 182 | 6 | DOID:423 (implicated_via_orthology) | |
| Disease | cardiovascular disease | TDRD15 NPR1 NPR3 MYO9B MECOM APOB PDE10A ADCY9 MEPE THADA ERAP2 SMARCA4 HSPA4 | 5.80e-06 | 457 | 182 | 13 | EFO_0000319 |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 1.26e-05 | 8 | 182 | 3 | EFO_0008589, EFO_0008595 | |
| Disease | biliary tract cancer (is_marker_for) | 3.78e-05 | 2 | 182 | 2 | DOID:4607 (is_marker_for) | |
| Disease | C-reactive protein measurement | SETD9 TDRD15 PCYT1A MYH2 NUP210L TRMT11 APOB PTBP1 PDE10A ADCY9 CYFIP2 SLC38A1 OR4A16 TLE4 SMARCA4 FAM227A SLITRK6 UVRAG TOP2B AFF4 | 5.98e-05 | 1206 | 182 | 20 | EFO_0004458 |
| Disease | osteoarthritis, hand | 7.89e-05 | 37 | 182 | 4 | EFO_1000789 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 7.99e-05 | 14 | 182 | 3 | EFO_0004611, EFO_0008589 | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 1.13e-04 | 3 | 182 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | migraine disorder, age at onset | 1.13e-04 | 3 | 182 | 2 | EFO_0004847, MONDO_0005277 | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 1.22e-04 | 16 | 182 | 3 | EFO_0000668, MONDO_0024664 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.40e-04 | 80 | 182 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | Familial dilated cardiomyopathy | 1.57e-04 | 44 | 182 | 4 | C0340427 | |
| Disease | polyunsaturated fatty acid measurement | 1.67e-04 | 131 | 182 | 6 | EFO_0010733 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 1.76e-04 | 18 | 182 | 3 | EFO_0008317, EFO_0008589 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 2.32e-04 | 197 | 182 | 7 | EFO_0005680 | |
| Disease | Antihypertensive use measurement | 2.54e-04 | 265 | 182 | 8 | EFO_0009927 | |
| Disease | gastric ulcer | 2.83e-04 | 21 | 182 | 3 | EFO_0009454 | |
| Disease | response to bronchodilator, response to corticosteroid | 3.74e-04 | 5 | 182 | 2 | GO_0031960, GO_0097366 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 3.78e-04 | 99 | 182 | 5 | EFO_0004611, EFO_0007878 | |
| Disease | Paroxysmal atrial fibrillation | 4.29e-04 | 156 | 182 | 6 | C0235480 | |
| Disease | familial atrial fibrillation | 4.29e-04 | 156 | 182 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.29e-04 | 156 | 182 | 6 | C2585653 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 4.34e-04 | 102 | 182 | 5 | EFO_0004329, EFO_0004611 | |
| Disease | Weight Gain | 4.34e-04 | 102 | 182 | 5 | C0043094 | |
| Disease | Atrial Fibrillation | 4.90e-04 | 160 | 182 | 6 | C0004238 | |
| Disease | familial hyperlipidemia | 5.18e-04 | 106 | 182 | 5 | MONDO_0001336 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 5.41e-04 | 26 | 182 | 3 | OBA_2045194 | |
| Disease | APOE carrier status, dementia | 5.91e-04 | 62 | 182 | 4 | EFO_0007659, MONDO_0001627 | |
| Disease | cholesterol to total lipids in medium LDL percentage | 6.05e-04 | 27 | 182 | 3 | EFO_0022238 | |
| Disease | Primary familial dilated cardiomyopathy | 8.29e-04 | 30 | 182 | 3 | cv:C0340427 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 8.86e-04 | 69 | 182 | 4 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | thyroid stimulating hormone measurement | 9.33e-04 | 323 | 182 | 8 | EFO_0004748 | |
| Disease | Abnormality of refraction | CCDC91 ZHX3 NEBL MYO5B ESRRG PTBP1 TFAM ADD3 GRAMD1B LDB3 FER1L4 ZFHX3 | 1.02e-03 | 673 | 182 | 12 | HP_0000539 |
| Disease | sick sinus syndrome | 1.03e-03 | 8 | 182 | 2 | MONDO_0001823 | |
| Disease | familial sick sinus syndrome | 1.03e-03 | 8 | 182 | 2 | MONDO_0012061 | |
| Disease | mean arterial pressure | 1.13e-03 | 499 | 182 | 10 | EFO_0006340 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 1.18e-03 | 335 | 182 | 8 | EFO_0009931 | |
| Disease | Primary dilated cardiomyopathy | 1.20e-03 | 34 | 182 | 3 | cv:C0007193 | |
| Disease | tea consumption measurement | 1.25e-03 | 129 | 182 | 5 | EFO_0010091 | |
| Disease | choline measurement | 1.30e-03 | 130 | 182 | 5 | EFO_0010116 | |
| Disease | Cardiomyopathies | 1.30e-03 | 130 | 182 | 5 | C0878544 | |
| Disease | autosomal dominant compelling helio-ophthalmic outburst syndrome | 1.33e-03 | 77 | 182 | 4 | EFO_0007887 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 1.54e-03 | 37 | 182 | 3 | EFO_0022281 | |
| Disease | myocardial infarction | 1.55e-03 | 350 | 182 | 8 | EFO_0000612 | |
| Disease | Facies | 1.65e-03 | 10 | 182 | 2 | C0282631 | |
| Disease | trochanter bone mineral density | 1.65e-03 | 10 | 182 | 2 | EFO_0020095 | |
| Disease | bone quantitative ultrasound measurement | 1.79e-03 | 39 | 182 | 3 | EFO_0004514 | |
| Disease | cholesterol in very small VLDL measurement | 1.93e-03 | 40 | 182 | 3 | EFO_0022231 | |
| Disease | free cholesterol in medium LDL measurement | 1.93e-03 | 40 | 182 | 3 | EFO_0022268 | |
| Disease | phosphatidylcholine measurement | 1.99e-03 | 284 | 182 | 7 | EFO_0010226 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.01e-03 | 86 | 182 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.24e-03 | 215 | 182 | 6 | EFO_0008317, EFO_0008591 | |
| Disease | resting heart rate | 2.36e-03 | 149 | 182 | 5 | EFO_0004351 | |
| Disease | lipid measurement, lipoprotein measurement | 2.37e-03 | 90 | 182 | 4 | EFO_0004529, EFO_0004732 | |
| Disease | retinal nerve fibre layer thickness measurement | 2.38e-03 | 43 | 182 | 3 | EFO_0600004 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 2.38e-03 | 43 | 182 | 3 | EFO_0022290 | |
| Disease | age at assessment, pelvic organ prolapse | 2.38e-03 | 43 | 182 | 3 | EFO_0004710, EFO_0008007 | |
| Disease | Pulmonary Thromboembolisms | 2.40e-03 | 12 | 182 | 2 | C0524702 | |
| Disease | Pulmonary Embolism | 2.40e-03 | 12 | 182 | 2 | C0034065 | |
| Disease | Abruptio Placentae | 2.40e-03 | 12 | 182 | 2 | EFO_1001754 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.47e-03 | 91 | 182 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 2.51e-03 | 220 | 182 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | concentration of large LDL particles measurement | 2.54e-03 | 44 | 182 | 3 | EFO_0022160 | |
| Disease | cholesterol in medium VLDL measurement | 2.54e-03 | 44 | 182 | 3 | EFO_0022225 | |
| Disease | QRS duration | 2.60e-03 | 298 | 182 | 7 | EFO_0005055 | |
| Disease | saturated fatty acids measurement | 2.71e-03 | 45 | 182 | 3 | EFO_0022304 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 2.71e-03 | 45 | 182 | 3 | EFO_0022236 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 2.81e-03 | 225 | 182 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 3.06e-03 | 229 | 182 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | free cholesterol in very small VLDL measurement | 3.07e-03 | 47 | 182 | 3 | EFO_0022275 | |
| Disease | Cardiomyopathy | 3.07e-03 | 47 | 182 | 3 | cv:C0878544 | |
| Disease | autism | 3.26e-03 | 48 | 182 | 3 | EFO_0003758 | |
| Disease | total lipids in lipoprotein particles measurement | 3.26e-03 | 48 | 182 | 3 | EFO_0022309 | |
| Disease | fertility measurement | 3.28e-03 | 14 | 182 | 2 | EFO_0006923 | |
| Disease | phospholipids in medium LDL measurement | 3.45e-03 | 49 | 182 | 3 | EFO_0022183 | |
| Disease | cholesteryl ester 20:3 measurement | 3.45e-03 | 49 | 182 | 3 | EFO_0010347 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 3.45e-03 | 49 | 182 | 3 | EFO_0022256 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 3.59e-03 | 101 | 182 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | free cholesterol in LDL measurement | 3.66e-03 | 50 | 182 | 3 | EFO_0022266 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 3.76e-03 | 166 | 182 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | low density lipoprotein triglyceride measurement | 3.77e-03 | 15 | 182 | 2 | EFO_0009946 | |
| Disease | Autosomal recessive primary microcephaly | 3.77e-03 | 15 | 182 | 2 | cv:C3711387 | |
| Disease | response to statin, LDL cholesterol change measurement | 3.77e-03 | 15 | 182 | 2 | EFO_0007804, GO_0036273 | |
| Disease | amenorrhea, response to antineoplastic agent | 3.77e-03 | 15 | 182 | 2 | EFO_0010269, GO_0097327 | |
| Disease | chronic obstructive pulmonary disease | CCDC91 FAM184A NEBL ESRRG MECOM FREM3 FRMD4A TMTC1 CAPZA3 HSPA4 TOP2B | 3.78e-03 | 688 | 182 | 11 | EFO_0000341 |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.78e-03 | 239 | 182 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | free cholesterol in large LDL measurement | 3.87e-03 | 51 | 182 | 3 | EFO_0022176 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQHFIYDISAKTKAL | 616 | Q9UKU6 | |
| EKNLKYISIHNLEAS | 51 | P43235 | |
| HQSKLSFKYDLLQNQ | 86 | Q96KX2 | |
| NYFDKHLKELQDNFS | 496 | F5H4B4 | |
| HQFLEQSKYKVINKD | 236 | Q92564 | |
| NPDTLFQDESYKKHL | 1556 | Q9HCK8 | |
| TKEQQHTRKLYFAQS | 926 | Q9P2K9 | |
| LIQEALVFDNKHTNY | 701 | P35609 | |
| AEKAKHQLNYFLNQE | 401 | Q96M83 | |
| HQLNYFLNQEKLLKS | 406 | Q96M83 | |
| TQLRTHYDVNLFKNK | 1251 | Q96M83 | |
| QLYRQFKKDIDEHQS | 666 | Q76N32 | |
| YKNKKFNLDALVTHT | 341 | P08319 | |
| DNLHVLDFQKYKAFT | 331 | Q9UEY8 | |
| KKEEHNYSLFVSDNL | 331 | Q8IUR6 | |
| YFISNDNHLGKFKLD | 3021 | Q6V0I7 | |
| TLSNYQTNKAKHDEL | 81 | P04080 | |
| IENNKTFLNIKHYSI | 5006 | Q86UQ4 | |
| NYIFSHAQVTKKNLL | 1026 | Q13085 | |
| INKFKSFHETLLNYD | 116 | Q4L235 | |
| AQATFQAHRDKYEKL | 261 | P53365 | |
| SDYSEKIIKANHLDN | 146 | Q9NR22 | |
| KANYQTLKAEHTRLQ | 46 | Q9Y592 | |
| KRQYLTTKEQFHQFL | 31 | Q96G46 | |
| LKQLKHLAYEQFNFT | 326 | P16066 | |
| LAYHLKETDALQKNS | 236 | Q8ND07 | |
| NKTHSENLKQDILYL | 256 | O75071 | |
| LTKVIYALNTKNDEH | 51 | Q8NB25 | |
| DTEKSQQALVQKRHY | 151 | P24539 | |
| LLESQQKYHDTELQK | 681 | Q3KR37 | |
| KTLTEHLKNSYNNSQ | 1026 | Q9UHB7 | |
| TVQKLAHQIYQFTDK | 116 | P35318 | |
| SELKNVKHRLNFEYE | 1116 | Q6IQ32 | |
| DKHDFEAKQAYSSLQ | 306 | P17342 | |
| ELYTDNQHLKKTIFD | 666 | Q96SN8 | |
| AHKDSDALTLQKYAQ | 151 | Q9UFE4 | |
| AKKETSNLYKLQFHN | 66 | O75323 | |
| HITVLNSYILFKKDN | 461 | Q96DM1 | |
| SNFKSNLHKVYQAIE | 6 | O95453 | |
| SINNKKEYSNHSIFS | 631 | Q03112 | |
| VKNDHSAYKRAAQFL | 181 | Q7L576 | |
| NCEHIKSFDKNLYRQ | 211 | P33991 | |
| ALISYQHKFQDDDQT | 306 | Q9NVH1 | |
| KFNQHSVSYQDLTKN | 456 | Q9BQK8 | |
| KVKAFHYESNNDLEK | 186 | Q92619 | |
| KIISSFKNKEDQYDH | 711 | P34932 | |
| THLEAQNKIKSASYN | 61 | O75112 | |
| VHDFNKKLTAYLDLN | 146 | Q9Y287 | |
| LNKEYSISNKENTHN | 96 | Q9NQ76 | |
| AKKAQTLASNQDYKH | 1126 | Q86VF7 | |
| AHQLQSDVKYKSDLN | 1646 | Q86VF7 | |
| IQYFHKTVSDLIDQK | 56 | Q9Y262 | |
| LEQNLYDFLKQNKFS | 271 | Q86Z02 | |
| LKIYNRSLKEEFNHF | 1171 | A9Z1Z3 | |
| TFSHSYLELKKEQEQ | 456 | Q8TDN1 | |
| DKCLNFLQDHSYKNQ | 936 | Q5H9U9 | |
| EENHLNSKIAYKIVS | 186 | Q86SJ6 | |
| HKELFDFYNKLETIQ | 181 | Q9Y6G5 | |
| ATDTSFKNKLYDQHL | 546 | P13535 | |
| NVSFINEKKYHLQER | 231 | P49585 | |
| IKDSKAYFHLLNQIA | 296 | P13797 | |
| NFLKTYSQEERHKAL | 221 | Q8NH70 | |
| ATDTSFKNKLYDQHL | 546 | Q9UKX2 | |
| QVDHKNKELYSDLFD | 291 | Q9Y233 | |
| SHNKLDKDNLSYIEH | 51 | Q15121 | |
| VDHKSSKELQQYLAN | 2091 | Q8IVL0 | |
| SEFHNYNLDLKKSDF | 16 | P26718 | |
| EKLQEYFNKHIFSLE | 456 | Q9HD67 | |
| TLYNKNIETHLKEFL | 1046 | P55160 | |
| TNYQIKKLDLSHNQF | 216 | Q0VAA2 | |
| KYFHSQNLQKAVTTE | 516 | Q8TB73 | |
| ATDTSFKNKLYEQHL | 546 | P12882 | |
| VKNDHSAYKRAAQFL | 181 | Q96F07 | |
| LKNSEQETLQKYSHL | 1976 | A2RRP1 | |
| EFSFEKLKNSNHAAY | 126 | Q06190 | |
| YNLKKGQTHTLEDFQ | 101 | Q99714 | |
| NHDINNELKKLASCY | 286 | O75344 | |
| NRFVQYKATSLEKQH | 56 | Q8N7H5 | |
| DVALKNFAKYFLHQS | 46 | P02794 | |
| AISQHQFYLDRKQSK | 311 | Q9P2Q2 | |
| ISQHQFYLDRKQSKA | 351 | Q9Y2L6 | |
| LTLDSNTKYFHKLNI | 2881 | P04114 | |
| AIATKKIISDYHQQF | 4481 | P04114 | |
| LNRNKETKEIYSHFT | 311 | P19086 | |
| VTDYKKNLDLTEHFQ | 1001 | Q6ZP82 | |
| SLQLEQFSHAKYNKI | 1041 | Q92608 | |
| SKADYSSILQKFNHE | 186 | Q96RU3 | |
| AISFQDRYKELQEKH | 181 | Q7Z6B0 | |
| NENERFAHYLEKTFK | 251 | Q5T2R2 | |
| QQLEALEKTFQKTHY | 81 | Q8NFW5 | |
| LGNKNLHFLTTQEDY | 156 | Q08830 | |
| QTSTKAVQHFYNIKL | 426 | P62508 | |
| QAKLQLITHAYFEEK | 131 | Q8NBF6 | |
| LYQLKKASQSQLFHS | 1141 | Q5TH69 | |
| RNSHYSKAATQLKDV | 106 | O15063 | |
| VNIAHLKNSQEKYSN | 151 | P53634 | |
| SHEQEYKNNIAKLVS | 106 | Q4G0S7 | |
| QLFEHDKDLKVVNSY | 1926 | Q9BZC7 | |
| AEQLKVSQTYSKNHD | 1041 | O60503 | |
| YNDDLIHFSKSENCK | 641 | Q02410 | |
| SLFEYQKNNKDSHSL | 91 | P02671 | |
| DKRNQTHYALQASLK | 291 | Q6P179 | |
| QNKILYALSTSKHQE | 821 | Q6P179 | |
| ESNELHEKQKFYLRQ | 96 | Q5M9N0 | |
| NKNLYLNKAVNFSDH | 536 | Q9NVP4 | |
| SKNTEFLKHQAVNNY | 221 | Q9NVL8 | |
| QHLKNADYNITTRKT | 3036 | Q9NZJ4 | |
| SIEFKQFSTKHIQQY | 211 | Q68D06 | |
| YLQTKHIEKLFTANQ | 2146 | Q02224 | |
| SKKLEHSNDPFNVYI | 71 | A0A087WTH5 | |
| FILFHNPEYNKNTSK | 56 | P20273 | |
| FYINQSELVLSHKQD | 1696 | Q5VU65 | |
| LHQLYSAAFSKQKLQ | 371 | Q6UXH9 | |
| FKENYSHLNAKKIVS | 756 | A8MW92 | |
| FTKQDLNKNLISYKH | 1596 | P0C091 | |
| THYFIDLNKKENKNS | 81 | Q96FC7 | |
| SLKTHLQVKNSFAYQ | 91 | O75691 | |
| VNTDYKSSLKHFQLA | 176 | O14607 | |
| FEHKGYSNAQKTILL | 166 | Q9P2Y5 | |
| VKKFENRDQYSHLLS | 416 | Q7Z4G4 | |
| NDYFNQAKILKEHDS | 1001 | Q6YHU6 | |
| TKNEYFELKANLHAE | 816 | Q9H5Y7 | |
| TKHLTYNDFINKELI | 711 | Q02880 | |
| QVADLKAFSKHIYNA | 171 | Q03181 | |
| KKYHSNNLVENNLSL | 706 | B5MCY1 | |
| QHNYTEAFESLQKKT | 186 | Q9UL63 | |
| AEYKHFKFSDLLNNK | 846 | Q8NE09 | |
| NISKHKYQSRESFLD | 1556 | P21675 | |
| NHEKYDNSLKIISNA | 136 | P04406 | |
| YAKNETLENLKQIHF | 1076 | Q9UPR0 | |
| NTKKENYISNHTLAE | 1031 | Q15858 | |
| LNSILQHAKDFKEYH | 476 | P51532 | |
| SVKSKYQDLLAVEHQ | 81 | Q8NE22 | |
| YFENKVLSKEFHLNE | 146 | Q01105 | |
| ATDTSFKNKLYEQHL | 546 | Q9Y623 | |
| HYFIDLNKKENKNSN | 36 | Q92561 | |
| DHYLREVQAFASNKK | 206 | Q13017 | |
| NLSDSEKELYIQHAK | 191 | Q00059 | |
| KLLSSLDIDHNQYKF | 746 | P13533 | |
| DLIHIYKSFKNAIQD | 136 | Q9H930 | |
| SHFEYQKNAQIEKLR | 226 | Q86YF9 | |
| NEKDVDKFLLYQHFS | 411 | Q8N5C6 | |
| KLSDSNKENALHSYS | 1896 | Q9H2D6 | |
| DFDKLKKSNAHYNLQ | 221 | Q01082 | |
| LENNSYKFLKDTANH | 786 | Q8NFU7 | |
| EFHNQYRLNSLKEEK | 141 | Q8IYE0 | |
| TISLDYKKFLNEHLQ | 191 | Q8N3C0 | |
| DHTRAVNYFSKVKQL | 1431 | Q00610 | |
| SYQKALQSHLKNSDS | 531 | Q7Z460 | |
| KNYTHIFESNNLIKF | 771 | A4UGR9 | |
| DKYVKVLHKFSNSNI | 181 | Q14593 | |
| LYLEQLQNKHSDTTK | 861 | Q92574 | |
| YCDKSFTKNFDLQQH | 326 | Q9BYN7 | |
| LLSAIYSKQENHDKA | 756 | Q8IUR5 | |
| KYLSVHLKAEHQNND | 686 | Q13129 | |
| KEEFQFLQAQYHSLK | 36 | Q04727 | |
| LDEFATKLIQNNHYA | 526 | Q13813 | |
| QQFSNDKHNYLSQVK | 91 | Q9H5I1 | |
| AFNQYSTLNKHKIIH | 461 | P0DPD5 | |
| LAHFLQKNKEYVSIA | 416 | Q9NUY8 | |
| NHVFTEDNLKKLYVS | 71 | Q06203 | |
| FTNSLKTKSQYHDLQ | 121 | Q9H788 | |
| HEIKNSFKNNYEKAL | 116 | O43657 | |
| SKYDRLQNKIVHFSA | 56 | P47989 | |
| ADLLQTKLQQSSYHK | 726 | O95347 | |
| YLINNRKEESSKHQA | 271 | Q9H8X9 | |
| LTPKQDFYEEHQSQK | 96 | Q96NI8 | |
| NHDTFELYIKTLKSN | 126 | O94892 | |
| EKSFNYSSALEQHKR | 511 | Q8NB50 | |
| YAFHTLEKSLKQKSN | 216 | P0CG31 | |
| LDSNVKHFLNDLYQQ | 1271 | Q9BXT5 | |
| FYLLQKITKDNNAHT | 341 | Q96QU8 | |
| NHDTFDLYRKNLKSS | 126 | Q8N883 | |
| YLINTRKEESSKHQA | 271 | P0C7U3 | |
| FLDASIYKNKKSHEQ | 491 | Q9H4I2 | |
| IYIQFSNHKELKTDS | 126 | P26599 | |
| KCDSEILYNNHKFTN | 366 | P08575 | |
| ILYNNHKFTNASKII | 371 | P08575 | |
| HEELKKQYIFQLSSL | 1261 | Q92547 | |
| LENFENHKKFYCSEL | 971 | P15822 | |
| NVQSDLLHKYQSKDD | 336 | Q9H2H9 | |
| QSKHRDKYLLFNLSE | 166 | Q63HR2 | |
| FNTKYFQLKNVTEHL | 1386 | Q5VZL5 | |
| QLLYDAIKHQKSSNN | 776 | Q9NYU2 | |
| NLYHFLEVNKQKETF | 506 | Q9NX78 | |
| THLKQQLALYTEKFE | 381 | P40222 | |
| KESFTQKNILLVHYN | 1551 | Q15911 | |
| KSQSNIHVLFQYKSV | 506 | A8MPX8 | |
| FINNLKKRFDHSEIY | 31 | O43795 | |
| IYNLSKKHDQQLTDH | 601 | Q9Y3Q0 | |
| KQNEHCLKNFDLTEY | 1576 | Q9ULV0 | |
| TLLAKFKQQHEDNKY | 606 | Q13459 | |
| KHQSNISYRKDVQDT | 156 | O76041 | |
| KDAQANITNTNYKHL | 2126 | P20929 | |
| HAKKSYDLQSQLQYT | 4621 | P20929 |